WO2003041728A1 - Novel phenyl-propargylether derivatives - Google Patents

Novel phenyl-propargylether derivatives Download PDF

Info

Publication number
WO2003041728A1
WO2003041728A1 PCT/EP2002/012848 EP0212848W WO03041728A1 WO 2003041728 A1 WO2003041728 A1 WO 2003041728A1 EP 0212848 W EP0212848 W EP 0212848W WO 03041728 A1 WO03041728 A1 WO 03041728A1
Authority
WO
WIPO (PCT)
Prior art keywords
phenyl
ynyloxy
prop
methoxy
ethyl
Prior art date
Application number
PCT/EP2002/012848
Other languages
French (fr)
Other versions
WO2003041728A9 (en
WO2003041728A8 (en
Inventor
Martin Zeller
Clemens Lamberth
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Priority to US10/495,153 priority Critical patent/US20050026785A1/en
Priority to AT02798312T priority patent/ATE292108T1/en
Priority to CA2464807A priority patent/CA2464807C/en
Priority to BR0214139-6A priority patent/BR0214139A/en
Priority to CN028226925A priority patent/CN101421230B/en
Priority to JP2003543615A priority patent/JP4510455B2/en
Priority to MXPA04004550A priority patent/MXPA04004550A/en
Priority to AU2002363600A priority patent/AU2002363600A1/en
Priority to EP02798312A priority patent/EP1444197B1/en
Priority to DE60203534T priority patent/DE60203534T2/en
Publication of WO2003041728A1 publication Critical patent/WO2003041728A1/en
Publication of WO2003041728A8 publication Critical patent/WO2003041728A8/en
Publication of WO2003041728A9 publication Critical patent/WO2003041728A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/31—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Definitions

  • the present invention relates to novel enantiomeric forms of phenyl-propargylether derivatives of formula I below. It relates to the preparation of those enantiomeric substances and to agrochemical compositions comprising at least one of the compounds of formula I as active ingredient. The invention relates also to the preparation of the said compositions and to the use of the compounds or of the compositions in controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi.
  • the invention relates to phenyl-propargylether derivatives of the general formula I
  • Ri is hydrogen, alkyl, cycloalkyl or optionally substituted aryl
  • R 2 and R 3 are each independently hydrogen or alkyl
  • R 4 is alkyl, alkenyl or alkynyl
  • R ⁇ , R71 and R 8 are each independently hydrogen or alkyl
  • R 9 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl or optionally substituted alkynyl,
  • R 10 is optionally substituted aryl or optionally substituted heteroaryl
  • Z is optionally substituted aryloxy, optionally substituted alkoxy, optionally substituted alkenyloxy or optionally substituted alkynyloxy
  • the compounds of formula I is understood to encompass the pure enantiomer of the displayed formula I as well as substantially enantio-enriched forms, as usually obtained from large scale synthesis processes.
  • the asymmetrical carbon atom to which the enantiomeric form of present invention relates is the alpha-carbon atom in the carboxylic acid, forming the amide function in the compounds of formula I.
  • This carbon atom is marked in formula I with the indication of the absolute configuration according to the Cahn-lngold-Prelog rules.
  • R 9 is hydrogen
  • R 0 is the optionally substituted phenyl moiety
  • Z is any defined radical
  • the asymmetrically substituted carbon atom is in the (S)-configuration.
  • the enantio-enriched forms according to present invention contain 70% or more of the pure enantiomer of formula I, while the difference to 100% of the compound of formula I is the mirror-image enantiomer.
  • the formerly known compounds of formula have been obtained in racemic forms, with in general comprised about equal amounts of the two enantiomer forms.
  • the amount of the enantiomer in the compounds of formula I is above 80%, more preferred above 90%, especially above 95%, for example 97%, 98% or 99%.
  • optical isomers are only those isomers which result from other possible asymmetrical elements in the molecule, if present, but not to the carbon atom in alpha- position of the amide functional group which is defined with its absolute configuration.
  • aryl includes aromatic hydrocarbon rings like phenyl, naphthyl, anthracenyl, phenanthrenyl and biphenyl like 1 ,3-biphenyl and 1 ,4-biphenyl, with phenyl being preferred.
  • aryl is part of aryloxy or arylthio.
  • Heteroaryl stands for aromatic ring systems comprising mono-, bi- or tricyclic systems wherein at least one oxygen, nitrogen or sulfur atom is present as a ring member.
  • Examples are furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, tria- zinyl, tetrazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, indazolyl, benzotria- zolyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, phthalazinyl, quinoxalinyl, quinazolinyl, cinnolinyl and naphthyridinyl.
  • aryl and heteroaryl groups may be optionally substituted. This means that they may carry one or more identical or different substituents. Normally not more than three substituents are present at the same time.
  • substituents of aryl or heteroaryl groups are: alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenyl-alkyl, it being possible in turn for all of the preceding groups to carry one or more identical or different halogen atoms; alkoxy; alkenyloxy; alkynyloxy; alkoxyalkyl; haloalkoxy, alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylami- no; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl; or
  • Typical examples include 4-chlorophenyl, 4-bromophenyl, 3,4-dichlorophenyl, 4-chloro-3-flu- orophenyl, 3-chloro-4-fluorophenyl, 4-methylphenyl, 4-ethylphenyl, 4-propargyloxyphenyl, 1-naphtyl, 2-naphtyl, 4-biphenylyl, 4'-chloro-4-biphenylyl, 5-chloro-thien2-yl, 5-methyl-thien- 2-yl, 5-methyl-fur-2-yl, 5,6,7,8-tetrahydro-1-naphthyl, 5,6,7,8-tetrahydro-2-naphthyl, 3,4dio- xomethylenyl-phenyl, 3,4-dioxoethylenyl-phenyl, 6-benzothienyl, 7-benzothienyl, 3-me-
  • Optionally substituted alkyl, alkenyl or alkynyl groups may carry one or more substituents selected from halogen, alkyl, alkoxy, alkylthio, cycloalkyl, phenyl, nitro, cyano, hydroxy, mer- capto, alkylcarbonyl or alkoxycarbonyl.
  • alkyl, alkenyl or alkynyl is part of another substituent like alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkenylyoxy, alke- nylthio, alkenylsulfinyl, alkenylsufonyl, alkynyloxy, alkynylthio, alkynylsulfinyl and alkynylsulfonyl.
  • the number of substituents is no more than three with the exception of halogen, where the alkyl groups may be perhalogenated.
  • halogen includes fluorine, chlorine, bromine and iodine.
  • alkyl, alkenyl and alkynyl radicals may be straight-chain or branched. This applies also to the alkyl, alkenyl or alkynyl parts of other alkyl-, alkenyl- or alkynyl-containing groups.
  • alkyl on its own or as part of another substituent is to be understood as being, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl and the isomers thereof, for example isopropyl, isobutyl, tert-butyl or sec-butyl, isopentyl or tert-pentyl.
  • Cycloalkyl is, depending upon the number of carbon atoms mentioned, cyclopropyl, cyclo- butyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.
  • Alkynyl as a group or as a structural element of other groups is, for example -C- ⁇ CH, -CH 2 -C ⁇ CH, -C ⁇ C-CH 3 , -CH 2 -C ⁇ C-CH 3 , -CH 2 -C ⁇ 2 -C ⁇ CH, -C ⁇ C-CH 2 -CH 3 , -CH 2 -CH(CH 3 )-C ⁇ CH, -C ⁇ C-(CH 2 ) 2 -CH 3 , -CH 2 -CH 2 -C ⁇ C-CH 3 , -CH(CH 3 )-CH 2 -C ⁇ C-CH 3 , -CH 2 -CH 2 -C ⁇ C-CH 2 -CH3, -C ⁇ C-(CH 2 )3-CH 3 , -C ⁇ C-(CH 2 ) 4 -CH 3 , -CH(CH 3 )-C ⁇ CH, -CH(CH 3 )-C ⁇ C-CH 3 , -CH
  • a haloalkyl group may contain one or more (identical or different) halogen atoms, and for example may stand for CHCI l CH 2 F, CCI 3 , CH 2 CI, CHF 2 , CF 3 , CH 2 CH 2 Br, C 2 CI 5 , CH 2 Br, CHCIBr, CF 3 CH 2 , etc..
  • RT is hydrogen, alkyl, cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by substituents selected from the group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may in turn be substituted by one or several halogens; alkoxy; alkenyloxy; alkynyloxy; alkoxy-alkyl; haloalk- oxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl; or alkynyloxycarbonyl; or ⁇ is hydrogen, d-
  • Ri is hydrogen, C ⁇ -C 8 alkyl or phenyl optionally substituted by one to three substituents selected from the group comprising C C 8 alkyl, C C 8 haloalkyl, CrC 8 alkoxy, d-C 8 halo- alkoxy, CrC 8 alkylthio, CrC 8 haloalkylthio, halogen, cyano, nitro and CrC 8 alkoxycarbonyl; or
  • Ri is hydrogen, d-C 8 alkyl or C 3 -C 8 cycloalkyl
  • Ri is hydrogen or C C alkyl
  • R 2 and R 3 are independently of each other hydrogen or C C 4 alkyl; or
  • R 2 and R 3 are hydrogen;
  • R is C C 8 alkyl, C 2 -C 8 alkenyl, or C 2 -C 8 alkynyl; or
  • R 4 is C C 6 alkyl
  • R 4 is C C 4 alkyl, or
  • R 4 is methyl or ethyl, especially methyl
  • R 5 , R 6 , R and R 8 are independently of each other hydrogen or CrC 4 alkyl; or
  • R 5 , R 6 and R 7 are hydrogen and R 8 is hydrogen, methyl or ethyl, preferably methyl; or
  • R ⁇ > Re, R7 and R 8 are hydrogen;
  • R 9 is hydrogen, C ⁇ -C 4 alkyl, d-C 4 haloalkyl, C 3 -C 4 alkenyl or C 3 -C 4 alkynyl; or
  • R 9 is hydrogen or C C ⁇ lkyl
  • R 9 is hydrogen
  • R 10 is aryl or heteroaryl, each optionally substituted with substituents selected from the group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may be substituted with one or more halogen atoms; alkoxy; alkenyloxy; alkynyloxy; alkoxy-alkyl; haloalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alka- noyl; hydroxy; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl and alkynyloxycarbonyl; or
  • R 10 is phenyl, naphthyl or biphenyl, each optionally substituted by one to three substituents selected from the group comprising CrCsalkyl, C -C 8 alkenyl, C 2 -C 8 alkynyl, C r C 8 halo- alkyl, d-C 8 alkoxy, C C 8 haloalkoxy, C C 8 alkylthio, C r C 8 haloalkylthio, d-C 8 aIkylsulfonyl, halogen, cyano, nitro and C C 8 alkoxycarbonyl; or
  • R 10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising C C 8 alkyl, C C 8 haloalkyl, CrC 8 alkoxy, C C 8 haloalkoxy, C ⁇ -C 8 alkylthio, C C 8 haloalkylthio, halogen, cyano, nitro and C ⁇ -C 8 alkoxycarbonyl; or
  • Z is optionally substituted aryloxy wherein the aryl may be optionally substituted by one or more substituents selected from the group comprising halogen, C ⁇ -C 8 alkoxy, C 2 -C 8 al- kenyloxy, C 2 -C 8 alkynyloxy, d-Csalkoxy-d-Csalkyl, C C 8 haloalkoxy, C C 8 alkylthio, CrCahaloalkylthio, C ⁇ -C 8 aIkylsulfonyl, formyl, C 2 -C 8 alkanoyl, hydroxy, halogen, cyano, nitro, amino, C C 8 alkylamino, di-C C 8 alkylamino, carboxyl and d-C 8 alkoxycarbonyl; or is optionally substituted C C 8 alkoxy, optionally substituted C 2 -C 8 alkenyloxy or optionally substituted C 2 -C 8 alkynyloxy wherein
  • Z is CrCsalkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 alkynyloxy, CrC 8 alkoxy-C C 8 alkoxy, C 2 -C 8 al- kenyloxy-C C 8 alkoxy, C ⁇ Csalkynyloxy-CrCaalkoxy, C C 8 haloalkoxy or C 3 -C 8 cycloaI- kyl-d-C 8 alkoxy; or
  • Z is CrC 8 alkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 alkynyloxy or CrC 4 alkoxy-d-C 2 alkoxy; or
  • Z is C C 8 alkoxy, C 2 -C 6 alkenyloxy or C 2 -C 6 alkynyloxy.
  • One preferred subgroup of the compounds of formula I consists of those compounds wherein R 9 is hydrogen, and Z is C C 8 alkoxy, C 2 -C 6 alkenyloxy or C 2 -C 6 alkynyloxy.
  • Ri is hydrogen, alkyl, cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by substituents selected from the group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may in turn be substituted by one or several halogens; alkoxy, alkenyloxy, alkynyloxy; alkoxy-alkyl; haloal- koxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl; or alkynyl- oxycarbonyl; and R 4 is alkyl;
  • Ri is hydrogen, d-C 8 alkyl, C 3 -C 8 cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by one to three substituents selected from the group comprising C C 8 alkyl, C -C 8 alkenyl, C 2 -C 8 alkynyl, C C 8 haloalkyl, CrC 8 alkoxy, CrC 8 haloalkoxy, CrC 8 alkylthio, CrC 8 haloalkylthio, C C 8 alkylsulfonyl, halogen, cyano, nitro and C C 8 al- koxycarbonyl; and R 2 , R 3 , R 5 , Re, and R 7 are hydrogen; and R 4 and R 8 are independently d-C 6 alkyl; and R 10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each
  • R 1 is hydrogen, C C 8 alkyl, phenyl optionally substituted by one to three substituents selected from the group comprising CrCealkyl, CrC 8 haloalkyl, C ⁇ -C 8 alkoxy, C C 8 haloal- koxy, d-C 8 alkylthio, CrC 8 haloalkylthio, halogen, cyano, nitro and CrC 8 alkoxycarbonyl; and R2, R3, R5, Re, and R 7 are hydrogen; and R 4 and R 8 are each independently methyl or ethyl; and R 10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising CrC 8 alkyl, d-C 8 haloalkyl, C C 8 al- koxy, C C 8 haloalkoxy, d-C 8 alkylthio, C
  • R is hydrogen, alkyl, cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by substituents selected from the group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may in turn be substituted by one or several halogens; alkoxy, alkenyloxy, alkynyloxy; alkoxy-alkyl; haloalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl; or alkynyloxycarbonyl; and
  • R 2 and R 3 are independently of each other hydrogen or Crdalkyl; and R 4 is C ⁇ -C 8 alkyl, C 2 -C 8 alkenyl, or C 2 -C 8 alkynyl; and
  • R5, Re, R7 and R 8 are independently of each other hydrogen or C C 4 alkyl; and R 9 is hydrogen, C C ⁇ lkyl, C C haloalkyl, C 3 -C 4 alkenyl or C 3 -C 4 alkynyl; and R 10 is aryl or heteroaryl, each optionally substituted with substituents selected from to group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may be substituted with one or more substituents selected from the group comprising halogen; alkoxy, alkenyloxy, alkynyloxy; alkoxy-alkyl; haloalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; cyano; nitro; amino; alkylamino; dialkyla
  • Ri is hydrogen, C C 8 alkyl, C 3 -C 8 cycloaIkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by one to three substituents selected from the group comprising C C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C C 8 haloalkyl, C C 8 alkoxy, C ⁇ -C 8 haloalkoxy, C r C 8 alkylthio, C C 8 haloaIkylthio, d-C 8 alkylsulfonyl, halogen, cyano, nitro and C C 8 al- koxycarbonyl; and R 2 and R 3 are hydrogen; and R 4 is d-C 6 alkyl; and
  • R 5 , R 6 and R 7 are hydrogen and R 8 is hydrogen, methyl or ethyl, preferably methyl; and R 9 is hydrogen or d-C 4 alkyl; and
  • R 10 is phenyl, naphthyl or biphenyl, each optionally substituted by one to three substituents selected from the group comprising C C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, d-C 8 haloalkyl, C C 8 alkoxy, C C 8 haloalkoxy, C C 8 alkylthio, C C 8 haloalkylthio, CrC 8 alkylsulfonyl, halogen, cyano, nitro and C C 8 alkoxycarbonyl; and
  • Z is C C 8 alkoxy, C 2 -C 8 alkenyloxy, d-C 8 alkynyloxy, C 1 -C 8 alkoxy-C 1 -C 8 alkoxy, C 2 -C 8 alke- nyloxy-CrC 8 aIkoxy, C 2 -C 8 aIkynyloxy-C C 8 alkoxy, C C 8 haloalkoxy or C 3 -C 8 cycloal- kyl-C ⁇ -C 8 alkoxy; or wherein
  • Ri is hydrogen, d-C 8 alkyl or phenyl optionally substituted by one to three substituents selected from the group comprising C C 8 alkyl, CrCshaloalkyl, CrC 8 aIkoxy, CrC 8 haloal- koxy, C ⁇ -C 8 aIkylthio, CrC 8 haloalkylthio, halogen, cyano, nitro and d-C 8 alkoxycarbonyl; and R 2 and R 3 are hydrogen; and
  • R is C C 4 alkyl
  • R 5 , R 6 and R 7 are hydrogen and R 8 is hydrogen or methyl
  • Rg is hydrogen
  • R 10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising d-C 8 alkyl, C ⁇ -C 8 haloalkyl, d-C 8 al- koxy, C C 8 haloalkoxy, C C 8 alkylthio, C ⁇ -C 8 haloalkyIthio, halogen, cyano, nitro and C r C 8 al- koxycarbonyl; and
  • Z is C ⁇ -C 8 alkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 alkynyloxy or CrC 4 alkoxy-CrC 2 alkoxy; or wherein
  • Ri is hydrogen, C ⁇ -C 8 alkyl or C 3 -C 8 cycloalkyl; and R 2 , R 3 , Re, R ⁇ , R7, Rs and R 9 are hydrogen; and R 4 is methyl or ethyl; and
  • R 10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising C ⁇ -C 8 alkyl, d-C 8 haloalkyl, d-C 8 al- koxy, CrCahaloalkoxy, CrC 8 alkylthio, d-C 8 haloalkylthio, halogen, cyano, nitro and d-C 8 al- koxycarbonyl; and Z is d-C 8 alkoxy, C 2 -C 6 alkenyloxy or C 2 -C 6 alkynyloxy.
  • Preferred individual compounds are:
  • racemic mandelic acid derivatives have been proposed for controlling plant- destructive fungi (for example in WO 94/29267, in WO 96/17840 and in PCT/EP01/05530).
  • the action of those racemic derivatives is not, however, satisfactory in all aspects of agri- cultural needs.
  • new microbiocides having a high level of activity have been found.
  • the enantiomeric propargylether derivatives of formula I and displayed subformulae and intermediates may be obtained either by separation methods from the racemic products having the same molecular design, or by stereoselective synthesis methods starting from optically active pure isomers of the starting materials via defined stereoselective processes and pure optical isomers of the intermediates according to one of the processes of Schemes 1 and 2.
  • Step A The acid of formula II or a carboxy-activated derivative of an acid of formula II wherein Rg, Rio and Z are as defined for formula I is reacted with an amine of formula III wherein R 4 , R 5 , R 6 , R and R 8 are as defined for formula I, optionally in the presence of a base and optionally in the presence of a diluting agent.
  • Carboxy-activated derivatives of the acid of formula II are all compounds having an activa- ted carboxyl group like an acid halide, such as an acid chloride, like symmetrical or mixed anhydrides, such as mixed anhydrides with O-alkylcarbonates, like activated esters, such as p-nitrophenylesters or N-hydroxysuccinimidesters, as well as in-situ-formed activated forms of the acid of formula II with condensating agents, such as dicyclohexylcarbodiimide, carbo- nyldiimidazole, benzotriazol-1 -yloxy-tris(dimethylamino)phosphonium hexafluorophosphate, O-benzotriazol-1 -yI-N,N,N',N'-bis(pentamethylene)uronium hexafluorophosphate, O-ben- zotriazol-1 -yl-N,N,N',N'-
  • the mixed anhydrides of the acids of the formula II may be prepared by reaction of an acid of formula II with chloroformic acid esters like chloroformic acid alkylesters, such as ethyl chloroformate or isobutyl chloroformate, optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethyla- mine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine.
  • chloroformic acid esters like chloroformic acid alkylesters, such as ethyl chloroformate or isobutyl chloroformate
  • an organic or inorganic base like a tertiary amine, such as triethyla- mine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine.
  • the present reaction is preferably performed in a solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones e.g. acetone; esters e.g. ethyl acetate; amides e.g. N,N-dimethylform- amide; nitriles e.g. acetonitrile; or ethers e.g. diethylether, tert-butyl-methylether, dioxane or tetrahydrofurane or water. It is also possible to use mixtures of these solvents.
  • aromatic, non-aromatic or halogenated hydrocarbons such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones e.g. acetone; esters e.g. ethyl acetate; amides e.g. N,N
  • the reaction is performed optionally in the presence of an organic or inorganic base like a tertiary amine, e.g. triethylamine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl- morpholine, like a metal hydroxide or a metal carbonate, preferentially an alkali hydroxide or an alkali carbonate, such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures ranging from -80°C to +150°C, preferentially at temperatures ranging from -40°C to +40°C.
  • an organic or inorganic base like a tertiary amine, e.g. triethylamine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl- morpholine, like a metal hydroxide or a metal carbonate, preferentially an alkali hydro
  • Step B The compounds of formula I may then finally be prepared by reacting a phenol of formula IV wherein R 4 , R 5 , R 6 , R 7 , R 8 , Rg, R 10 and Z are as defined for formula I with a compound of formula V wherein R ( R 2 and R 3 are as defined for formula I and wherein Y is a leaving group like a halide such as a chloride or bromide or a sulfonic ester such as a tosylate, mesylate or triflate.
  • a halide such as a chloride or bromide
  • a sulfonic ester such as a tosylate, mesylate or triflate.
  • the reaction is advantageously performed in a solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones e.g. acetone or 2-butanone; esters e.g. ethyl acetate; ethers e.g. diethylether, tert-butyl- methylether, dioxane or tetrahydrofurane, amides e.g. dimethylformamide, nitriles e.g. ace- tonitrile, alcohols e.g.
  • a solvent like aromatic, non-aromatic or halogenated hydrocarbons such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones e.g. acetone or 2-butanone; esters e.g. ethyl acetate; ethers e.g. diethyl
  • reaction is performed optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperldine or N-methyl-morpholine, like a metal hydroxide, a metal carbonate or a metal alkoxide, preferentially an alkali hydroxide, an alkali carbonate or an alkali alkoxide, such as lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, sodium tert-butoxide or potassium tert-but
  • Step C Alternatively to step A and step B, the (S)-form of an acid of formula II or a carboxy- activated derivative of an acid of formula II wherein R 9 , R ⁇ 0 and Z are as defined for formula I is reacted with an amine of formula VI wherein R 1 ? R 2 , R 3 , R 4 , R 5 , R 6 , R and R 8 are as defined for formula I under the same conditions as defined for step A, optionally in the presence of a base and optionally in the presence of a diluting agent.
  • Step D A compound of formula VII wherein R 4 , R 5 , R 6 , R 7 and R 8 are as defined for formula I is alkylated with a compound of formula V (see Scheme 1 ) wherein Ri, R 2 , R 3 and Y are as defined for Scheme 1 under the same conditions as defined for step B in Scheme 1.
  • Step E A compound of formula VIII wherein R 1 ; R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as defined for formula I is dehydrated to an isocyanide of formula IX wherein R ⁇ R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as defined for formula I under conditions known per se (D. Seebach, G. Adam, T. Gees, M. Schiess, W. Weigang, Chem. Ber. 1988, 121, 507).
  • Step F An isocyanide of formula IX wherein R ⁇ R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as defined for formula I is reacted in a three-component Passerini reaction (J. March, Advanced Organic Chemistry, 4th ed., Wiley, 1992, p.
  • R 980 with an aldehyde or ketone of formula X, wherein R 9 and R ⁇ 0 are as defined for formula I in the presence of a chiral carboxylic acid XI, typically an amino acid or a sugar acid like a glyconic acid or a glycuronic acid, preferably a glycuronic acid like 1 ,2,3,4-tetra-O-acetyl- ⁇ -D-galacturonic acid or 1 ,2,3,4-tetra-O- acetyl- ⁇ -D-glucuronic acid to give a O-acyl- ⁇ -hydroxy amide of formula XII, wherein R 1 ( R 2 , R 3 , R , R 5 , R 6 , R ) R 8 , R 9 and R 10 are as defined for formula I.
  • R 1 ( R 2 , R 3 , R , R 5 , R 6 , R ) R 8 , R 9 and R 10 are as defined for formula I.
  • the reaction is advantageously performed in a solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones e.g. acetone or 2-butanone; esters e.g. ethyl acetate; ethers e.g. diethylether, tert-butyl-methylether, dioxane or tetrahydrofuran, amides e.g. dimethylformamide, nitriles e.g. acetonitrile, alcohols e.g. methanol, ethanol, isopropanol, n-butanol or tert-butanol, sulfoxides e.g. dimethylsulfoxide or water. It is also possible to use mixtures of these solvents.
  • aromatic, non-aromatic or halogenated hydrocarbons such as chlorohydrocarbons e.g.
  • Step G The O-acyl- ⁇ -hydroxy amide of formula XII wherein Ri, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and Rn are as defined above is hydrolyzed to a an ⁇ -hydroxy amide of formula XIII, wherein R 1 f R 2 , R 3 , R , Rs, Re, R7 , Ra, 9 and R 10 are as defined for formula I under classical conditions (J. March, Advanced Organic Chemistry, 4th ed., Wiley, 1992).
  • Step H The ⁇ -hydroxy amide of formula XIII wherein R 1 ( R 2 , R 3 , R 4 , R 5 , R 6 , R7, Rs, 9 and R 10 are as defined for formula I is reacted with a compound XIV wherein R 12 is alkyl, alkenyl or alkynyl and Y is a leaving group like a halide such as a chloride or bromide or a sulfonic ester such as a tosylate, mesylate or triflate to a compound of formula la wherein R ⁇ R 2 , R 3 , R 4 , R5, Re, R7, Rs, R9 and R 10 are as defined for formula I and R 12 is alkyl, alkenyl or alkynyl under the same conditions as defined for step B in Scheme 1.
  • R 1 R 2 , R 3 , R 4 , R 5 , R 6 , R7, Rs, 9 and R 10 are as defined for formula I is reacted with a
  • the compounds of formula I are oils or solids at room temperature and are distinguished by valuable microbiocidal properties. They can be used in the agricultural sector or related fields preventatively and curatively in the control of plant-destructive microorganisms.
  • the compounds of formula I according to the invention are distinguished at low rates of concentration not only by outstanding microbiocidal, especially fungicidal, activity but also by being especially well tolerated by plants.
  • the compounds of formula I have for practical purposes a very advantageous microbiocidal spectrum in the control of phytopathogenic microorganisms, especially fungi. They possess very advantageous curative and preventive properties and are used in the protection of numerous crop plants. With the compounds of formula I it is possible to inhibit or destroy phytopathogenic microorganisms that occur on various crops of useful plants or on parts of such plants (fruit, blossom, leaves, stems, tubers, roots), while parts of the plants which grow later also remain protected, for example, against phytopathogenic fungi.
  • novel compounds of formula I prove to be effective against specific genera of the fungus class Fungi imperfecti (e.g. Cercospora), Basidiomycetes (e.g. Puccinia) and Ascomycetes (e.g. Erysiphe and Venturia) and especially against Oomycetes (e.g. Plasmopara, Peronospora, Pythium and Phytophthora). They therefore represent in plant protection a valuable addition to the compositions for controlling phytopathogenic fungi.
  • the compounds of formula I can also be used as dressings for protecting seed (fruit, tubers, grains) and plant cuttings from fungal infections and against phytopathogenic fungi that occur in the soil.
  • the invention relates also to compositions comprising compounds of formula I as active ingredient, especially plant-protecting compositions, and to the use thereof in the agricultural sector or related fields.
  • the present invention includes the preparation of those compositions, wherein the active ingredient is homogeneously mixed with one or more of the substances or groups of substances described herein. Also included is a method of treating plants which is distinguished by the application of the novel compounds of formula I or of the novel compositions.
  • Target crops to be protected within the scope of this invention comprise, for example, the following species of plants: cereals (wheat, barley, rye, oats, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pomes, stone fruit and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas, soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts); cucurbi- taceae (marrows, cucumbers, melons); fibre plants (cotton, flax, hemp, jute); citrus fruit (oranges, lemons, grapefruit, mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika); lauraceae (avocado, cinnamon, camphor) and
  • the compounds of formula I are normally used in the form of compositions and can be applied to the area or plant to be treated simultaneously or in succession with other active ingredients.
  • Those other active ingredients may be fertilisers, micronutrient donors or other preparations that influence plant growth. It is also possible to use selective herbicides or insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of those preparations, if desired together with further carriers, surfactants or other application- promoting adjuvants customarily employed in formulation technology.
  • the compounds of formula I can be mixed with other fungicides, resulting in some cases in unexpected synergistic activities.
  • Such mixtures are not limited to two active ingredients (one of formula I and one of the list of other fungicides), but to the contrary many comprise more than one active ingredient of the component of formula I and more than one other fungicide.
  • Mixing components which are particularly suited for this purpose include e.g.
  • azoles such as azaconazole, BAY 14120, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, pyrifenox, prochloraz, propiconazole, simeconazole, tebucon- azole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole; pyrimidinyl carbi- noles, such as ancymidol, fenarimol, nuarimol; 2-amino-pyrimidines, such as bupirimate, di
  • Some particularly interesting mixtures in view of technical value in the agricultural practice comprising at least the one mentioned compound of formula I together with the above mentioned mentioned other fungicide, but not being limited thereto, i.e. such mixtures may comprise additional components according to needs when controlling certain fungi on certain crop plants) , having enhanced synergistic levels of fungicidal activity, or being especially well suited for the control of persistent or very damaging phytopathogenic fungi are among the following:
  • the mixture ratio of the active ingredients is so selected that it reaches optional control of the phytopathogenic microorganism on the host plants.
  • This ratio is in general between 100:1 and 1 :100, preferably between 50: 1 and 1 : 100, more preferably between 10:1 and 1 :10, most preferably between 5:1 and 1 : 10 of a compound of formula I vis-a-vis the second fungicide.
  • the mixtures may not only comprise one of the listed combinational active ingredients, but may comprise more than one additional active ingredients selected from that specified group, thus forming for example 3-way- or even 4-way-mixtures.
  • Suitable carriers and surfactants may be solid or liquid and correspond to the substances ordinarily employed in formulation technology, such as e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilisers. Such carriers and additives are described, for example, in WO 95/30651.
  • a preferred method of applying a compound of formula I, or an agrochemical composition comprising at least one of those compounds, is application to the foliage (foliar application), the frequency and the rate of application depending upon the risk of infestation by the pathogen in question.
  • the compounds of formula I may also be applied to seed grains (coating) either by impregnating the grains with a liquid formulation of the active ingredient or by coating them with a solid formulation.
  • the compounds of formula I are used in unmodified form or, preferably, together with the adjuvants conventionally employed in formulation technology, and are for that purpose advantageously formulated in known manner e.g. into emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules, and by encapsulation in e.g. polymer substances.
  • the methods of application such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances.
  • Advantageous rates of application are normally from 1 g to 2 kg of active ingredient (a.i.) per hectare (ha), preferably from 5 g to 1 kg a.i./ha, preferably from 25 g to 750 g a.i./ha, especially from 10 g to 500g a.i./ha, more preferably from 5 g to 500g a.i./ha. Most preferred is 5g to 250 g a.i./ha .
  • rates of from 0.001 g to 1.0 g of active ingredient per kg of seed are advantageously used.
  • compositions, preparations or mixtures comprising the compound ⁇ ) (active ingredient(s)) of formula I and, where appropriate, a solid or liquid adjuvant are prepared in known manner, e.g. by homogeneously mixing and/or grinding the active ingredient with extenders, e.g. solvents, solid carriers and, where appropriate, surface-active compounds (surfactants).
  • extenders e.g. solvents, solid carriers and, where appropriate, surface-active compounds (surfactants).
  • surfactants surface-active compounds
  • the agrochemical compositions usually comprise 0.01 to 99 % by weight, preferably 0.1 to 95 % by weight, of a compound of formula I, 99.99 to 1 % by weight, preferably 99.9 to 5 % by weight, of a solid or liquid adjuvant, and 0 to 25 % by weight, preferably 0.1 to 25 % by weight, of a surfactant.
  • compositions may also comprise further ingredients, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as fertilisers or other active ingredients for obtaining special effects.
  • further ingredients such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as fertilisers or other active ingredients for obtaining special effects.
  • Formulations may be prepared analogously to those described in, for example, WO 95/30651.
  • Biological Examples may be prepared analogously to those described in, for example, WO 95/30651.
  • Vine seedlings are sprayed at the 4- to 5-leaf stage with a spray mixture (0.02 % active ingredient) prepared from a wettable powder formulation of the test compound. After 24 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation for 6 days at 95-100 % relative humidity and +20°C. b) Residual-curative action
  • Vine seedlings are infected at the 4- to 5-leaf stage with a sporangia suspension of the fungus. After incubation for 24 hours in a humidity chamber at 95-100 % relative humidity and +20°C, the infected plants are dried and sprayed with a spray mixture (0.02 % active ingredient) prepared from a wettable powder formulation of the test compound. After the spray coating has dried, the treated plants are placed in the humidity chamber again. Fungus infestation is evaluated 6 days after infection.
  • Compounds of Tables 1 to 31 exhibit a good fungicidal action against Plasmopara viticola on vines.
  • Compounds E1.002, E1.011 and E1.152 at 200 ppm inhibit fungal infestations in both tests D-1 a) and D-1b) by 80-100%.
  • untreated plants showed pathogen attack of 80-100%.
  • tomato plants are watered with a spray mixture (0.02 % active ingredient based on the volume of the soil) prepared from a wettable powder formulation of the test compound. Care is taken that the spray mixture does not come into contact with the parts of the plants that are above the ground.
  • the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation of the infected plants for 4 days at 90-100 % relative humidity and +20°C.
  • Compounds of Tables 1 to 31 exhibit a long-lasting effect against fungus infestation.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention relates to phenyl-propargylether derivatives of the general formula I including the optical isomers thereof and mixtures of such osimers, wherein R1 is hydrogen, alkyl, cycloalkyl or optionally substituted aryl, R2 and R3 are each independently hydrogen or alkyl, R4 is alkyl, alkenal or alkynyl, R5, R6, R7, and R8 are each independently hydrogen or alkal, R9 is hydrogen, optionally substituted alkyl, optionnaly substituted alkenyl or optionally substituted alkynyl, R10 is optionally substituted aryl or optionaly substituted heteroaryl, and Z is optionally substituted aryloxy, optionally substituted alkoxy, optionally substituted alkenyloxy or optionally substituted alkynyloxy. These compounds possess useful plant protecting properties and may advantageously be employed in agricultural practice for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi.

Description

Novel Phenyl-Proparqylether Derivatives
The present invention relates to novel enantiomeric forms of phenyl-propargylether derivatives of formula I below. It relates to the preparation of those enantiomeric substances and to agrochemical compositions comprising at least one of the compounds of formula I as active ingredient. The invention relates also to the preparation of the said compositions and to the use of the compounds or of the compositions in controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi.
The invention relates to phenyl-propargylether derivatives of the general formula I
Figure imgf000002_0001
including the optical isomers thereof and mixtures of such isomers, wherein
Ri is hydrogen, alkyl, cycloalkyl or optionally substituted aryl,
R2 and R3 are each independently hydrogen or alkyl,
R4 is alkyl, alkenyl or alkynyl,
R5. Rδ, R71 and R8 are each independently hydrogen or alkyl,
R9 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl or optionally substituted alkynyl,
R10 is optionally substituted aryl or optionally substituted heteroaryl, and
Z is optionally substituted aryloxy, optionally substituted alkoxy, optionally substituted alkenyloxy or optionally substituted alkynyloxy
The compounds of formula I is understood to encompass the pure enantiomer of the displayed formula I as well as substantially enantio-enriched forms, as usually obtained from large scale synthesis processes. The asymmetrical carbon atom to which the enantiomeric form of present invention relates is the alpha-carbon atom in the carboxylic acid, forming the amide function in the compounds of formula I. This carbon atom is marked in formula I with the indication of the absolute configuration according to the Cahn-lngold-Prelog rules. For example, where R9 is hydrogen, R 0 is the optionally substituted phenyl moiety, and Z is any defined radical, the asymmetrically substituted carbon atom is in the (S)-configuration. The enantio-enriched forms according to present invention contain 70% or more of the pure enantiomer of formula I, while the difference to 100% of the compound of formula I is the mirror-image enantiomer. In contrast to present invention, the formerly known compounds of formula have been obtained in racemic forms, with in general comprised about equal amounts of the two enantiomer forms. In preferred embodiments of this invention the amount of the enantiomer in the compounds of formula I is above 80%, more preferred above 90%, especially above 95%, for example 97%, 98% or 99%.
The presence of more asymmetrical carbon atoms in the compounds of formula I , in addition to the alpha-carbon atom of the carboxylic, means that the enantiomers of compounds of formula I can occur in stereoisomeric forms, i.e. as several diastereomers. As a result of the presence of a possible aliphatic C=C double bond, also geometric isomerism may also occur. Formula I is intended to include all those possible diastereomeric forms of the enantiomer of formula I, and mixtures thereof.
Where the definition of formula I refers to optical isomers, for this document it shall be understood that the optical isomers are only those isomers which result from other possible asymmetrical elements in the molecule, if present, but not to the carbon atom in alpha- position of the amide functional group which is defined with its absolute configuration.
In the above definition aryl includes aromatic hydrocarbon rings like phenyl, naphthyl, anthracenyl, phenanthrenyl and biphenyl like 1 ,3-biphenyl and 1 ,4-biphenyl, with phenyl being preferred. The same definition applies where aryl is part of aryloxy or arylthio. Heteroaryl stands for aromatic ring systems comprising mono-, bi- or tricyclic systems wherein at least one oxygen, nitrogen or sulfur atom is present as a ring member. Examples are furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, tria- zinyl, tetrazinyl, indolyl, benzothiophenyl, benzofuranyl, benzimidazolyl, indazolyl, benzotria- zolyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, phthalazinyl, quinoxalinyl, quinazolinyl, cinnolinyl and naphthyridinyl.
The above aryl and heteroaryl groups may be optionally substituted. This means that they may carry one or more identical or different substituents. Normally not more than three substituents are present at the same time. Examples of substituents of aryl or heteroaryl groups are: alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenyl-alkyl, it being possible in turn for all of the preceding groups to carry one or more identical or different halogen atoms; alkoxy; alkenyloxy; alkynyloxy; alkoxyalkyl; haloalkoxy, alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylami- no; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl; or alkynyloxycarbonyl. Typical examples include 4-chlorophenyl, 4-bromophenyl, 3,4-dichlorophenyl, 4-chloro-3-flu- orophenyl, 3-chloro-4-fluorophenyl, 4-methylphenyl, 4-ethylphenyl, 4-propargyloxyphenyl, 1-naphtyl, 2-naphtyl, 4-biphenylyl, 4'-chloro-4-biphenylyl, 5-chloro-thien2-yl, 5-methyl-thien- 2-yl, 5-methyl-fur-2-yl, 5,6,7,8-tetrahydro-1-naphthyl, 5,6,7,8-tetrahydro-2-naphthyl, 3,4dio- xomethylenyl-phenyl, 3,4-dioxoethylenyl-phenyl, 6-benzothienyl, 7-benzothienyl, 3-me- thylphenyl, 4-fluorophenyl, 4-ethenylphenyl, 4-ethynylphenyl, 4-propylphenyl, 4-isopro- pylphenyl, 4-tert-butylphenyl, 4-ethoxyphenyl, 4-ethynyloxyphenyl, 4-phenoxyphenyl, 4-me- thylthiophenyl, 4-methylsulfonylphenyl, 4-cyanophenyl, 4-nitrophenyl, 4-methoxycarbonyl- phenyl, 3-bromophenyl, 3-chlorophenyl, 2-chlorophenyl, 2,4-dichlorophenyl, 3,4,5-trichloro- phenyl, 3,4-difluorophenyl, 3,4-dibromophenyl, 3,4-dimethoxyphenyl, 3,4-dimethylphenyl, 3-chloro-4-cyanophenyl, 4-chloro-3-cyanophenyl, 3-bromo-4-methylphenyl, 4-methoxy-3- methylphenyl, 3-fluoro-4-methoxyphenyl, 4-chloro-3-methylphenyl, 4-chloro-3-trifluorome- thyl-phenyl, 4-bromo-3-chlorophenyl, 4-trifluoromethylphenyl, 4-trifluoromethoxyphenyl, 4-methoxyphenyl, 4'-methyl-4-biphenylyl, 4'-trifluoromethyl-4-biphenylyl, 4'-bromo-4-biphe- nylyl, 4'-cyano-4-biphenylyl, 3'4'-dichloro-4-biphenylyl, etc. Again, the same optional substituent may be present where aryl is part of aryloxy. Optionally substituted alkyl, alkenyl or alkynyl groups may carry one or more substituents selected from halogen, alkyl, alkoxy, alkylthio, cycloalkyl, phenyl, nitro, cyano, hydroxy, mer- capto, alkylcarbonyl or alkoxycarbonyl. This also applies where alkyl, alkenyl or alkynyl is part of another substituent like alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkenylyoxy, alke- nylthio, alkenylsulfinyl, alkenylsufonyl, alkynyloxy, alkynylthio, alkynylsulfinyl and alkynylsulfonyl.
Preferably, the number of substituents is no more than three with the exception of halogen, where the alkyl groups may be perhalogenated.
In the above definitions "halogen" includes fluorine, chlorine, bromine and iodine. The alkyl, alkenyl and alkynyl radicals may be straight-chain or branched. This applies also to the alkyl, alkenyl or alkynyl parts of other alkyl-, alkenyl- or alkynyl-containing groups. Depending upon the number of carbon atoms mentioned, alkyl on its own or as part of another substituent is to be understood as being, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl and the isomers thereof, for example isopropyl, isobutyl, tert-butyl or sec-butyl, isopentyl or tert-pentyl. Cycloalkyl is, depending upon the number of carbon atoms mentioned, cyclopropyl, cyclo- butyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl.
Depending upon the number of carbon atoms mentioned, alkenyl as a group or as a structural element of other groups is to be understood as being, for example -CH=CH2, -CH2-CH=CH2, -CH=CH-CH3, -CH2-CH=CH-CH3) -CH2-CH2-CH=CH2, -CH2-CH(CH3)-CH=CH2, -CH2-C(CH3)=CH2, -CH=CH-(CH2)2-CH3, -CH2-CH2-CH=CH-CH3, -CH2-CH2-C(CH3)=CH-CH3, -CH(CH3)-CH2-CH=CH-CH3, -CH2-CH2-CH=CH-CH2-CH3, -CH=CH-(CH2)3-CH3, -CH2-CH2-CH=C(CH3)-CH3, -CH2-CH2-CH=C(CH3)-CH2-CH3, -C(CH3)=CH2, -CH(CH3)-CH=CH2, -C(CH3)=CH-CH3J -CH(CH3)-CH=CH-CH3, -CH(CH3)-CH2-CH=CH2, -CH2-CH(CH3)-C(CH3)=CH2, -CH2-C(CH3)=CH-CH3, -C(CH3)=CH-(CH2)2-CH3, -CH(CH3)-CH2-C(CH3)=CH-CH3, -CH(CH3)-(CH2)2-CH=CH2, -CH(CH3)-CH2-CH=CH-CH2-CH3, -C(CH3)=CH-(CH2)3-CH3, -(CH2)3-CH=CH2, -CH(CH3)-CH2-C(CH3)=CH-CH3l or -CH(CH3)-CH2-CH=CH-CH2-CH3 . Alkynyl as a group or as a structural element of other groups is, for example -C-≡CH, -CH2-C≡CH, -C≡C-CH3, -CH2-C≡C-CH3, -CH2-Cπ2-C≡CH, -C≡C-CH2-CH3, -CH2-CH(CH3)-C≡CH, -C≡C-(CH2)2-CH3, -CH2-CH2-C≡C-CH3, -CH(CH3)-CH2-C≡C-CH3, -CH2-CH2-C≡C-CH2-CH3, -C≡C-(CH2)3-CH3, -C≡C-(CH2)4-CH3, -CH(CH3)-C≡CH, -CH(CH3)-C≡C-CH3, -CH(C2H5)-C≡C-CH3, -CH(CH3)-CH2-C≡CH, -CH(CH3)-(CH2)2-C≡CH, -CH(CH3)-CH2-C≡C-CH2-CH3> -(CH2)3-C≡CH, or -CH(CH3)-CH2-C≡C-CH2-CH3 .depending on the number of carbon atoms present.
A haloalkyl group may contain one or more (identical or different) halogen atoms, and for example may stand for CHCI l CH2F, CCI3, CH2CI, CHF2, CF3, CH2CH2Br, C2CI5, CH2Br, CHCIBr, CF3CH2, etc..
Preferred subgroups of compounds of formula I are those wherein
RT is hydrogen, alkyl, cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by substituents selected from the group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may in turn be substituted by one or several halogens; alkoxy; alkenyloxy; alkynyloxy; alkoxy-alkyl; haloalk- oxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl; or alkynyloxycarbonyl; or ^ is hydrogen, d-Cβalkyl, C3-C8cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by one to three substituents selected from the group comprising C C8alkyl, C2-C8alkenyl, C2-C8alkynyl, Cι-C8haloalkyl, d-C8alkoxy, CrC8haloalkoxy, C C8alkylthio, Cι-C8haloalkylthio, C Csalkylsulfonyl, halogen, cyano, nitro and Cι-C8alkoxycarbonyl; or
Ri is hydrogen, Cι-C8alkyl or phenyl optionally substituted by one to three substituents selected from the group comprising C C8alkyl, C C8haloalkyl, CrC8alkoxy, d-C8halo- alkoxy, CrC8alkylthio, CrC8haloalkylthio, halogen, cyano, nitro and CrC8alkoxycarbonyl; or
Ri is hydrogen, d-C8alkyl or C3-C8cycloalkyl; or
Ri is hydrogen or C C alkyl; or
R2 and R3 are independently of each other hydrogen or C C4alkyl; or
R2 and R3 are hydrogen; or
R is C C8alkyl, C2-C8alkenyl, or C2-C8alkynyl; or
R4 is C C6alkyl; or
R4 is C C4alkyl, or
R4 is methyl or ethyl, especially methyl; or
R5, R6, R and R8 are independently of each other hydrogen or CrC4alkyl; or
R5, R6 and R7 are hydrogen and R8 is hydrogen, methyl or ethyl, preferably methyl; or
Rδ> Re, R7 and R8 are hydrogen; or
R9 is hydrogen, Cι-C4alkyl, d-C4haloalkyl, C3-C4alkenyl or C3-C4alkynyl; or
R9 is hydrogen or C C^lkyl; or
R9 is hydrogen; or
R10 is aryl or heteroaryl, each optionally substituted with substituents selected from the group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may be substituted with one or more halogen atoms; alkoxy; alkenyloxy; alkynyloxy; alkoxy-alkyl; haloalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alka- noyl; hydroxy; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl and alkynyloxycarbonyl; or
R10 is phenyl, naphthyl or biphenyl, each optionally substituted by one to three substituents selected from the group comprising CrCsalkyl, C -C8alkenyl, C2-C8alkynyl, CrC8halo- alkyl, d-C8alkoxy, C C8haloalkoxy, C C8alkylthio, CrC8haloalkylthio, d-C8aIkylsulfonyl, halogen, cyano, nitro and C C8alkoxycarbonyl; or
R10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising C C8alkyl, C C8haloalkyl, CrC8alkoxy, C C8haloalkoxy, Cι-C8alkylthio, C C8haloalkylthio, halogen, cyano, nitro and Cι-C8alkoxycarbonyl; or
Z is optionally substituted aryloxy wherein the aryl may be optionally substituted by one or more substituents selected from the group comprising halogen, Cι-C8alkoxy, C2-C8al- kenyloxy, C2-C8alkynyloxy, d-Csalkoxy-d-Csalkyl, C C8haloalkoxy, C C8alkylthio, CrCahaloalkylthio, Cι-C8aIkylsulfonyl, formyl, C2-C8alkanoyl, hydroxy, halogen, cyano, nitro, amino, C C8alkylamino, di-C C8alkylamino, carboxyl and d-C8alkoxycarbonyl; or is optionally substituted C C8alkoxy, optionally substituted C2-C8alkenyloxy or optionally substituted C2-C8alkynyloxy wherein each alkyl, alkenyl or alkynyl group may carry one or more substituents selected from the group comprising halogen, C C4alkyl, d-C4alkoxy, Cι-C4alkylthio, C3-C6cycloalkyI, nitro, cyano, hydroxy, phenyl, mercapto, d-C4alkylcarbonyl and C C4alkoxycarbonyl; or
Z is CrCsalkoxy, C2-C8alkenyloxy, C2-C8alkynyloxy, CrC8alkoxy-C C8alkoxy, C2-C8al- kenyloxy-C C8alkoxy, C^Csalkynyloxy-CrCaalkoxy, C C8haloalkoxy or C3-C8cycloaI- kyl-d-C8alkoxy; or
Z is CrC8alkoxy, C2-C8alkenyloxy, C2-C8alkynyloxy or CrC4alkoxy-d-C2alkoxy; or
Z is C C8alkoxy, C2-C6alkenyloxy or C2-C6alkynyloxy.
One preferred subgroup of the compounds of formula I consists of those compounds wherein R9 is hydrogen, and Z is C C8alkoxy, C2-C6alkenyloxy or C2-C6alkynyloxy.
Further preferred subgroups are those wherein
Ri is hydrogen, alkyl, cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by substituents selected from the group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may in turn be substituted by one or several halogens; alkoxy, alkenyloxy, alkynyloxy; alkoxy-alkyl; haloal- koxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl; or alkynyl- oxycarbonyl; and R4 is alkyl; and Rι0 is aryl or heteroaryl, each optionally substituted by substituents selected from to group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl- alkyl, phenyl and phenylalkyl, where all these groups may be substituted by one or several halogen; alkoxy; alkenyloxy; alkynyloxy; alkoxy-alkyl; haloalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl and alkynyloxycarbonyl; and Z is C C8alkoxy, C2-C6alkenyloxy or C2-C6alkynyloxy ; or
Ri is hydrogen, d-C8alkyl, C3-C8cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by one to three substituents selected from the group comprising C C8alkyl, C -C8alkenyl, C2-C8alkynyl, C C8haloalkyl, CrC8alkoxy, CrC8haloalkoxy, CrC8alkylthio, CrC8haloalkylthio, C C8alkylsulfonyl, halogen, cyano, nitro and C C8al- koxycarbonyl; and R2, R3, R5, Re, and R7 are hydrogen; and R4 and R8 are independently d-C6alkyl; and R10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising Cι-C8alkyl, C2-C8alke- nyl, C2-C8alkynyl, C C8haloalkyl, Cι-C8alkoxy, Cι-C8haloalkoxy, C C8alkylthio, Cι-C8haloal- kylthio, CrCsalkylsulfonyl, halogen, cyano, nitro and C C8alkoxycarbonyl; and R9 is hydrogen or C C4alkyl; and Z is C C8alkoxy, C2-C6alkenyloxy or C2-C6alkynyloxy; or
R1 is hydrogen, C C8alkyl, phenyl optionally substituted by one to three substituents selected from the group comprising CrCealkyl, CrC8haloalkyl, Cι-C8alkoxy, C C8haloal- koxy, d-C8alkylthio, CrC8haloalkylthio, halogen, cyano, nitro and CrC8alkoxycarbonyl; and R2, R3, R5, Re, and R7 are hydrogen; and R4 and R8 are each independently methyl or ethyl; and R10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising CrC8alkyl, d-C8haloalkyl, C C8al- koxy, C C8haloalkoxy, d-C8alkylthio, CrC8haloalkylthio, halogen, cyano, nitro and C C8al- koxycarbonyl; R9 is hydrogen and Z is C C8alkoxy, C2-C6alkenyIoxy or C2-C6alkynyloxy.
Other preferred subgroups of the compounds of formula I are those wherein
R is hydrogen, alkyl, cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by substituents selected from the group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may in turn be substituted by one or several halogens; alkoxy, alkenyloxy, alkynyloxy; alkoxy-alkyl; haloalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl; or alkynyloxycarbonyl; and
R2 and R3 are independently of each other hydrogen or Crdalkyl; and R4 is Cι-C8alkyl, C2-C8alkenyl, or C2-C8alkynyl; and
R5, Re, R7 and R8 are independently of each other hydrogen or C C4alkyl; and R9 is hydrogen, C C^lkyl, C C haloalkyl, C3-C4alkenyl or C3-C4alkynyl; and R10 is aryl or heteroaryl, each optionally substituted with substituents selected from to group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may be substituted with one or more substituents selected from the group comprising halogen; alkoxy, alkenyloxy, alkynyloxy; alkoxy-alkyl; haloalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl and alkynyloxycarbonyl; and Z is optionally substituted aryloxy wherein in each the aryl may be optionally substituted by one or more substituents selected from the group comprising halogen, CrCaalkoxy, C2-C8al- kenyloxy, C2-C8alkynyloxy, CrCsalkoxy-CrCaalkyl, C C8haloalkoxy, C C8alkylthio, Cι-C8haloalkylthio, C C8alkylsulfonyl, formyl, C2-C8alkanoyl, hydroxy, halogen, cyano, nitro, amino, C C8alkylamino, di-Cι-C8alkylamino, carboxyl and C C8alkoxycarbonyl; or is optionally substituted d-C8alkoxy, optionally substituted C2-C8alkenyloxy or optionally substituted C2-C8alkynyloxy, wherein each alkyl, alkenyl or alkynyl group may carry one or more substituents selected from the group comprising halogen, C C4alkyl, C C4alkoxy, C-i-C4al- kylthio, C3-C6cycloalkyl, nitro, cyano, hydroxy, phenyl, mercapto, d-C4alkylcarbonyl and C C4alkoxycarbonyl; or wherein
Ri is hydrogen, C C8alkyl, C3-C8cycloaIkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by one to three substituents selected from the group comprising C C8alkyl, C2-C8alkenyl, C2-C8alkynyl, C C8haloalkyl, C C8alkoxy, Cι-C8haloalkoxy, CrC8alkylthio, C C8haloaIkylthio, d-C8alkylsulfonyl, halogen, cyano, nitro and C C8al- koxycarbonyl; and R2 and R3 are hydrogen; and R4 is d-C6alkyl; and
R5, R6 and R7 are hydrogen and R8 is hydrogen, methyl or ethyl, preferably methyl; and R9 is hydrogen or d-C4alkyl; and
R10 is phenyl, naphthyl or biphenyl, each optionally substituted by one to three substituents selected from the group comprising C C8alkyl, C2-C8alkenyl, C2-C8alkynyl, d-C8haloalkyl, C C8alkoxy, C C8haloalkoxy, C C8alkylthio, C C8haloalkylthio, CrC8alkylsulfonyl, halogen, cyano, nitro and C C8alkoxycarbonyl; and
Z is C C8alkoxy, C2-C8alkenyloxy, d-C8alkynyloxy, C1-C8alkoxy-C1-C8alkoxy, C2-C8alke- nyloxy-CrC8aIkoxy, C2-C8aIkynyloxy-C C8alkoxy, C C8haloalkoxy or C3-C8cycloal- kyl-Cι-C8alkoxy; or wherein
Ri is hydrogen, d-C8alkyl or phenyl optionally substituted by one to three substituents selected from the group comprising C C8alkyl, CrCshaloalkyl, CrC8aIkoxy, CrC8haloal- koxy, Cι-C8aIkylthio, CrC8haloalkylthio, halogen, cyano, nitro and d-C8alkoxycarbonyl; and R2 and R3 are hydrogen; and
R is C C4alkyl, and
R5, R6 and R7 are hydrogen and R8 is hydrogen or methyl; and
Rg is hydrogen; and
R10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising d-C8alkyl, Cι-C8haloalkyl, d-C8al- koxy, C C8haloalkoxy, C C8alkylthio, Cι-C8haloalkyIthio, halogen, cyano, nitro and CrC8al- koxycarbonyl; and
Z is Cι-C8alkoxy, C2-C8alkenyloxy, C2-C8alkynyloxy or CrC4alkoxy-CrC2alkoxy; or wherein
Ri is hydrogen, Cι-C8alkyl or C3-C8cycloalkyl; and R2, R3, Re, Rδ, R7, Rs and R9 are hydrogen; and R4 is methyl or ethyl; and
R10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising Cι-C8alkyl, d-C8haloalkyl, d-C8al- koxy, CrCahaloalkoxy, CrC8alkylthio, d-C8haloalkylthio, halogen, cyano, nitro and d-C8al- koxycarbonyl; and Z is d-C8alkoxy, C2-C6alkenyloxy or C2-C6alkynyloxy.
Preferred individual compounds are:
(S)-2-(4-bromo-phenyl)-2-methoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-chloro-phenyl)-2-methoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(3,4-dichloro-phenyl)-2-methoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-bromo-phenyl)-2-ethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-chloro-phenyl)-2-ethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(3,4-dichloro-phenyl)-2-ethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-bromo-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-propoxy- acetamide, (S)-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-propoxy- acetamide,
(S)-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-propoxy- acetamide,
(S)-2-(4-bromo-phenyl)-2-cyclopropylmethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyI)- ethyl]-acetamide,
(S)-2-(4-chloro-phenyl)-2-cycIopropylmethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)- ethyl]-acetamide,
(S)-2-cyclopropylmethoxy-2-(3,4-dichIoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy- phenyl)-ethyl]-acetamide,
(S)-2-(4-bromo-phenyl)-2-ethoxymethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-chloro-phenyl)-2-ethoxymethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(3,4-dichloro-phenyl)-2-ethoxymethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)- ethylj-acetamide,
(S)-2-allyloxy-2-(4-bromo-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-allyloxy-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-aIlyloxy-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyI)-ethyI]- acetamide,
(S)-2-(4-bromo-phenyl)-2-(but-2-enyloxy)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(but-2-enyloxy)-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(but-2-enyloxy)-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)- ethyl]-acetamide,
(S)-2-(4-bromo-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyI)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide, (S)-2-biphenyl-4-yl-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyI)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-naphthalen-2-yl-2-prop-2-ynyloxy- acetamide,
(S)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy-2-p-tolyl-acetamide, 2-(4-ethyl-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy-2-(4-trifluoromethyl- phenyl)-acetamide,
(S)-2-(4-bromo-phenyl)-2-but-2-ynyloxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-but-2-ynyloxy-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-but-2-ynyloxy-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-bromo-phenyl)-N-[2-(3-methoxy-4-pent-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-pent-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-2-(3,4-dichIoro-phenyl)-N-[2-(3-methoxy-4-pent-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetam ide ,
(S)-2-(4-fluoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-2-(3,4-difluoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide,
(S)-2-(4-chloro-3-fluoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide, and
(S)-2-(3-chloro-4-fluoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyI)-ethyl]-2-prop-2- ynyloxy-acetamide.
Certain racemic mandelic acid derivatives have been proposed for controlling plant- destructive fungi (for example in WO 94/29267, in WO 96/17840 and in PCT/EP01/05530). The action of those racemic derivatives is not, however, satisfactory in all aspects of agri- cultural needs. Surprisingly, with the enantiomeric form of the compounds of formula I, new microbiocides having a high level of activity have been found.
The enantiomeric propargylether derivatives of formula I and displayed subformulae and intermediates may be obtained either by separation methods from the racemic products having the same molecular design, or by stereoselective synthesis methods starting from optically active pure isomers of the starting materials via defined stereoselective processes and pure optical isomers of the intermediates according to one of the processes of Schemes 1 and 2.
Scheme 1 :
Figure imgf000013_0001
IV
R6 R8 R10
Figure imgf000013_0002
Step A: The acid of formula II or a carboxy-activated derivative of an acid of formula II wherein Rg, Rio and Z are as defined for formula I is reacted with an amine of formula III wherein R4, R5, R6, R and R8 are as defined for formula I, optionally in the presence of a base and optionally in the presence of a diluting agent. Carboxy-activated derivatives of the acid of formula II are all compounds having an activa- ted carboxyl group like an acid halide, such as an acid chloride, like symmetrical or mixed anhydrides, such as mixed anhydrides with O-alkylcarbonates, like activated esters, such as p-nitrophenylesters or N-hydroxysuccinimidesters, as well as in-situ-formed activated forms of the acid of formula II with condensating agents, such as dicyclohexylcarbodiimide, carbo- nyldiimidazole, benzotriazol-1 -yloxy-tris(dimethylamino)phosphonium hexafluorophosphate, O-benzotriazol-1 -yI-N,N,N',N'-bis(pentamethylene)uronium hexafluorophosphate, O-ben- zotriazol-1 -yl-N,N,N',N'-bis(tetramethyIene)uronium hexafluorophosphate, O-benzotriazol-1 - yl-N,N,N',N'-tetramethyluronium hexafluorophosphate or benzotriazol-1 -yloxy-tripyrrolidino- phosphonium hexafluorophosphate. The mixed anhydrides of the acids of the formula II may be prepared by reaction of an acid of formula II with chloroformic acid esters like chloroformic acid alkylesters, such as ethyl chloroformate or isobutyl chloroformate, optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethyla- mine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl-morpholine.
The present reaction is preferably performed in a solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones e.g. acetone; esters e.g. ethyl acetate; amides e.g. N,N-dimethylform- amide; nitriles e.g. acetonitrile; or ethers e.g. diethylether, tert-butyl-methylether, dioxane or tetrahydrofurane or water. It is also possible to use mixtures of these solvents. The reaction is performed optionally in the presence of an organic or inorganic base like a tertiary amine, e.g. triethylamine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperidine or N-methyl- morpholine, like a metal hydroxide or a metal carbonate, preferentially an alkali hydroxide or an alkali carbonate, such as lithium hydroxide, sodium hydroxide or potassium hydroxide at temperatures ranging from -80°C to +150°C, preferentially at temperatures ranging from -40°C to +40°C.
Step B: The compounds of formula I may then finally be prepared by reacting a phenol of formula IV wherein R4, R5, R6, R7, R8, Rg, R10 and Z are as defined for formula I with a compound of formula V wherein R ( R2 and R3 are as defined for formula I and wherein Y is a leaving group like a halide such as a chloride or bromide or a sulfonic ester such as a tosylate, mesylate or triflate.
The reaction is advantageously performed in a solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones e.g. acetone or 2-butanone; esters e.g. ethyl acetate; ethers e.g. diethylether, tert-butyl- methylether, dioxane or tetrahydrofurane, amides e.g. dimethylformamide, nitriles e.g. ace- tonitrile, alcohols e.g. methanol, ethanol, isopropanol, n-butanol or tert-butanol, sulfoxides e.g. dimethylsulfoxide or water. It is also possible to use mixtures of these solvents. The reaction is performed optionally in the presence of an organic or inorganic base like a tertiary amine, such as triethylamine, N,N-diisopropyl-ethylamine, pyridine, N-methyl-piperldine or N-methyl-morpholine, like a metal hydroxide, a metal carbonate or a metal alkoxide, preferentially an alkali hydroxide, an alkali carbonate or an alkali alkoxide, such as lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methoxide, potassium methoxide, sodium ethoxide, potassium ethoxide, sodium tert-butoxide or potassium tert-butoxide at temperatures ranging from -80°C to +200°C, preferentially at temperatures ranging from 0°C to +120°C.
Step C: Alternatively to step A and step B, the (S)-form of an acid of formula II or a carboxy- activated derivative of an acid of formula II wherein R9, Rι0 and Z are as defined for formula I is reacted with an amine of formula VI wherein R1 ? R2, R3, R4, R5, R6, R and R8 are as defined for formula I under the same conditions as defined for step A, optionally in the presence of a base and optionally in the presence of a diluting agent.
Scheme 2: Preparation of compounds of subformula la:
Figure imgf000015_0001
Step D: A compound of formula VII wherein R4, R5, R6, R7 and R8 are as defined for formula I is alkylated with a compound of formula V (see Scheme 1 ) wherein Ri, R2, R3 and Y are as defined for Scheme 1 under the same conditions as defined for step B in Scheme 1. Step E: A compound of formula VIII wherein R1 ; R2, R3, R4, R5, R6, R7 and R8 are as defined for formula I is dehydrated to an isocyanide of formula IX wherein R^ R2, R3, R4, R5, R6, R7 and R8 are as defined for formula I under conditions known per se (D. Seebach, G. Adam, T. Gees, M. Schiess, W. Weigang, Chem. Ber. 1988, 121, 507).
Step F: An isocyanide of formula IX wherein R^ R2, R3, R4, R5, R6, R7 and R8 are as defined for formula I is reacted in a three-component Passerini reaction (J. March, Advanced Organic Chemistry, 4th ed., Wiley, 1992, p. 980) with an aldehyde or ketone of formula X, wherein R9 and Rι0 are as defined for formula I in the presence of a chiral carboxylic acid XI, typically an amino acid or a sugar acid like a glyconic acid or a glycuronic acid, preferably a glycuronic acid like 1 ,2,3,4-tetra-O-acetyl-α-D-galacturonic acid or 1 ,2,3,4-tetra-O- acetyl-α-D-glucuronic acid to give a O-acyl-α-hydroxy amide of formula XII, wherein R1 ( R2, R3, R , R5, R6, R ) R8, R9 and R10 are as defined for formula I. The reaction is advantageously performed in a solvent like aromatic, non-aromatic or halogenated hydrocarbons, such as chlorohydrocarbons e.g. dichloromethane or toluene; ketones e.g. acetone or 2-butanone; esters e.g. ethyl acetate; ethers e.g. diethylether, tert-butyl-methylether, dioxane or tetrahydrofuran, amides e.g. dimethylformamide, nitriles e.g. acetonitrile, alcohols e.g. methanol, ethanol, isopropanol, n-butanol or tert-butanol, sulfoxides e.g. dimethylsulfoxide or water. It is also possible to use mixtures of these solvents.
Step G: The O-acyl-α-hydroxy amide of formula XII wherein Ri, R2, R3, R4, R5, R6, R7, R8, R9, R10 and Rn are as defined above is hydrolyzed to a an α-hydroxy amide of formula XIII, wherein R1 f R2, R3, R , Rs, Re, R7 , Ra, 9 and R10 are as defined for formula I under classical conditions (J. March, Advanced Organic Chemistry, 4th ed., Wiley, 1992).
Step H: The α-hydroxy amide of formula XIII wherein R1 ( R2, R3, R4, R5, R6, R7, Rs, 9 and R10 are as defined for formula I is reacted with a compound XIV wherein R12 is alkyl, alkenyl or alkynyl and Y is a leaving group like a halide such as a chloride or bromide or a sulfonic ester such as a tosylate, mesylate or triflate to a compound of formula la wherein R^ R2, R3, R4, R5, Re, R7, Rs, R9 and R10 are as defined for formula I and R12 is alkyl, alkenyl or alkynyl under the same conditions as defined for step B in Scheme 1. The compounds of formula I are oils or solids at room temperature and are distinguished by valuable microbiocidal properties. They can be used in the agricultural sector or related fields preventatively and curatively in the control of plant-destructive microorganisms. The compounds of formula I according to the invention are distinguished at low rates of concentration not only by outstanding microbiocidal, especially fungicidal, activity but also by being especially well tolerated by plants.
Surprisingly, it has now been found that the compounds of formula I have for practical purposes a very advantageous microbiocidal spectrum in the control of phytopathogenic microorganisms, especially fungi. They possess very advantageous curative and preventive properties and are used in the protection of numerous crop plants. With the compounds of formula I it is possible to inhibit or destroy phytopathogenic microorganisms that occur on various crops of useful plants or on parts of such plants (fruit, blossom, leaves, stems, tubers, roots), while parts of the plants which grow later also remain protected, for example, against phytopathogenic fungi.
The novel compounds of formula I prove to be effective against specific genera of the fungus class Fungi imperfecti (e.g. Cercospora), Basidiomycetes (e.g. Puccinia) and Ascomycetes (e.g. Erysiphe and Venturia) and especially against Oomycetes (e.g. Plasmopara, Peronospora, Pythium and Phytophthora). They therefore represent in plant protection a valuable addition to the compositions for controlling phytopathogenic fungi. The compounds of formula I can also be used as dressings for protecting seed (fruit, tubers, grains) and plant cuttings from fungal infections and against phytopathogenic fungi that occur in the soil.
The invention relates also to compositions comprising compounds of formula I as active ingredient, especially plant-protecting compositions, and to the use thereof in the agricultural sector or related fields.
In addition, the present invention includes the preparation of those compositions, wherein the active ingredient is homogeneously mixed with one or more of the substances or groups of substances described herein. Also included is a method of treating plants which is distinguished by the application of the novel compounds of formula I or of the novel compositions. Target crops to be protected within the scope of this invention comprise, for example, the following species of plants: cereals (wheat, barley, rye, oats, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pomes, stone fruit and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas, soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts); cucurbi- taceae (marrows, cucumbers, melons); fibre plants (cotton, flax, hemp, jute); citrus fruit (oranges, lemons, grapefruit, mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika); lauraceae (avocado, cinnamon, camphor) and plants such as tobacco, nuts, coffee, sugar cane, tea, pepper, vines, hops, bananas and natural rubber plants, and also ornamentals.
The compounds of formula I are normally used in the form of compositions and can be applied to the area or plant to be treated simultaneously or in succession with other active ingredients. Those other active ingredients may be fertilisers, micronutrient donors or other preparations that influence plant growth. It is also possible to use selective herbicides or insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of those preparations, if desired together with further carriers, surfactants or other application- promoting adjuvants customarily employed in formulation technology.
The compounds of formula I can be mixed with other fungicides, resulting in some cases in unexpected synergistic activities. Such mixtures are not limited to two active ingredients (one of formula I and one of the list of other fungicides), but to the contrary many comprise more than one active ingredient of the component of formula I and more than one other fungicide. Mixing components which are particularly suited for this purpose include e.g. azoles, such as azaconazole, BAY 14120, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, pyrifenox, prochloraz, propiconazole, simeconazole, tebucon- azole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole; pyrimidinyl carbi- noles, such as ancymidol, fenarimol, nuarimol; 2-amino-pyrimidines, such as bupirimate, dimethirimol, ethirimol; morpholines, such as dodemorph, fenpropidine, fenpropimorph, spiroxamine, tridemorph; anilinopyrimidines, such as cyprodinil, mepanipyrim, pyrimethanil; pyrroles, such as fenpiclonil, fludioxonil; phenylamides, such as benalaxyl, furalaxyl, meta- laxyl, R-metalaxyl, ofurace, oxadixyl; benzimidazoles, such as benomyl, carbendazim, debacarb, fuberidazole, thiabendazole; dicarboximides, such as chlozolinate, dichlozoline, iprodione, myclozoline, procymidone, vinclozoline; carboxamides, such as carboxin, fenfuram, flutolanil, mepronil, oxycarboxin, thifluzamide; guanidines, such as guazatine, dodine, iminoctadine; strobilurines, such as azoxystrobin, kresoxim-methyl, metominostro- bin, SSF-129, trifloxystrobin, picoxystrobin, BAS 500F (proposed name pyraclostrobin), BAS 520; dithiocarbamates, such as ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb, ziram; N-halomethylthiotetrahydrophthalimides, such as captafol, captan, dichloflu- anid, fluoromides, folpet, tolyfluanid; Cu-compounds, such as Bordeaux mixture, copper hydroxide, copper oxychloride, copper sulfate, cuprous oxide, mancopper, oxine-copper; nitrophenol-derivatives, such as dinocap, nitrothal-isopropyl; organo-p-derivatives, such as edifenphos, iprobenphos, isoprothiolane, phosdiphen, pyrazophos, tolclofos-methyl; various others, such as acibenzolar-S-methyl, anilazine, benthiavalicarb, blasticidin-S, chinomethio- nate, chloroneb, chlorothalonil, cyflufenamid, cymoxanil, dichlone, diclomezine, dicloran, diethofencarb, dimethomorph, SYP-LI90 (proposed name: flumorph), dithianon, ethaboxam, etridiazole, famoxadone, fenamidone, fenoxanil, fentin, ferimzone, fluazinam, flusulfamide, fenhexamid, fosetyl-aluminium, hymexazol, iprovalicarb, IKF-916 (cyazofamid), kasugamycin, methasulfocarb, metrafenone, nicobifen (new proposal: boscalid), pencycuron, phthalide, polyoxins, probenazole, propamocarb, pyroquilon, quinoxyfen, quintozene, sulfur, triazoxide, tricyclazole, triforine, validamycin, zoxamide (RH7281).
Some particularly interesting mixtures in view of technical value in the agricultural practice (comprising at least the one mentioned compound of formula I together with the above mentioned mentioned other fungicide, but not being limited thereto, i.e. such mixtures may comprise additional components according to needs when controlling certain fungi on certain crop plants) , having enhanced synergistic levels of fungicidal activity, or being especially well suited for the control of persistent or very damaging phytopathogenic fungi are among the following:
1) (S)-2-phenyl-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyI]-2-prop-2-ynyloxy-aceta- mide(compound E1.002), combined with any one active ingredient selected from cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, metalaxyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S-methyl, fludioxo- nil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(methylsulfonyl-amino)-3- methyl-butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2-propyn-1 -yloxy)-phenyl}-ethyl]- amide; and
2) (S)-2-(4-chloro-phenyI)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyl- oxy-acetamide(compound E1.011), combined with any one active ingredient selected from cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, metala- xyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S- methyl, fludioxonil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(me- thylsulfonyl-amino)-3-methyl-butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2-propyn-1 - yloxy)-phenyl}-ethyl]-amide, and
3) (S)-2-(4-bromo-phenyI)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-yn- yloxy-acetamide (compound E1.022), combined with any one active ingredient selected from cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, meta- laxyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S- methyl, fludioxonil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(methylsul- fonyl-amino)-3-methyl-butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2-propyn-1 -yloxy)- phenyl}-ethyl]-amide, and
4) (S)-2-(4-fluoro-phenyI)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyl- oxy-acetamide (compound E1.033), combined with any one active ingredient selected from cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, metala- xyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S- methyl, fludioxonil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(methylsul- fonyl-amino)-3-methyl-butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2-propyn-1 -yloxy)- phenyl}-ethyl]-amide, and
5) (S)-2-(4-toIyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy-acet- amide (compound E1.045), combined with any one active ingredient selected from cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, metalaxyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S-methyl, fludioxonil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(methylsulfonyl-amino)- 3-methyl-butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2-propyn-1 -yloxy)-phenyl}- ethylj-amide, and
6) (S)-2-(4-ethyI-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyI- oxy-acetamide (compound E1.053), combined with any one active ingredient selected from cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, metalaxyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S-me- thyl, fludioxonil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(methylsulfo- nyl-amino)-3-methyl-butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2-propyn-1 -yloxy)- phenyl}-ethyl]-amide, and
7) (S)-2-(3,4-difluoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide (compound E1.085), combined with any one active ingredient selected from cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, meta- laxyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S- methyl, fludioxonil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(methylsul- fonyl-amino)-3-methyl-butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2-propyn-1 -yloxy)- phenyl}-ethyl]-amide, and
8) (S)-2-(3-fluoro-4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2- prop-2-ynyloxy-acetamide (compound E1.091), combined with any one active ingredient selected from cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, metalaxyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S-methyl, fludioxonil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(methylsulfonyl-amino)-3-methyl-butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2- propyn-1-yIoxy)-phenyl}-ethyl]-amide, and
9) (S)-2-(3,4-dichIoro-phenyI)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide (compound E1.102), combined with any one active ingredient selected from cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, metalaxyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S-methyl, fludioxonil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(me- thyIsulfonyl-amino)-3-methyl-butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2-propyn-1 - yloxy)-phenyl}-ethyl]-amide.
In the above mentioned mixtures, the mixture ratio of the active ingredients is so selected that it reaches optional control of the phytopathogenic microorganism on the host plants. This ratio is in general between 100:1 and 1 :100, preferably between 50: 1 and 1 : 100, more preferably between 10:1 and 1 :10, most preferably between 5:1 and 1 : 10 of a compound of formula I vis-a-vis the second fungicide. The mixtures may not only comprise one of the listed combinational active ingredients, but may comprise more than one additional active ingredients selected from that specified group, thus forming for example 3-way- or even 4-way-mixtures. Suitable carriers and surfactants may be solid or liquid and correspond to the substances ordinarily employed in formulation technology, such as e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilisers. Such carriers and additives are described, for example, in WO 95/30651.
A preferred method of applying a compound of formula I, or an agrochemical composition comprising at least one of those compounds, is application to the foliage (foliar application), the frequency and the rate of application depending upon the risk of infestation by the pathogen in question. The compounds of formula I may also be applied to seed grains (coating) either by impregnating the grains with a liquid formulation of the active ingredient or by coating them with a solid formulation.
The compounds of formula I are used in unmodified form or, preferably, together with the adjuvants conventionally employed in formulation technology, and are for that purpose advantageously formulated in known manner e.g. into emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granules, and by encapsulation in e.g. polymer substances. As with the nature of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances.
Advantageous rates of application are normally from 1 g to 2 kg of active ingredient (a.i.) per hectare (ha), preferably from 5 g to 1 kg a.i./ha, preferably from 25 g to 750 g a.i./ha, especially from 10 g to 500g a.i./ha, more preferably from 5 g to 500g a.i./ha. Most preferred is 5g to 250 g a.i./ha . When used as seed dressings, rates of from 0.001 g to 1.0 g of active ingredient per kg of seed are advantageously used.
The formulations, i.e. the compositions, preparations or mixtures comprising the compound^) (active ingredient(s)) of formula I and, where appropriate, a solid or liquid adjuvant, are prepared in known manner, e.g. by homogeneously mixing and/or grinding the active ingredient with extenders, e.g. solvents, solid carriers and, where appropriate, surface-active compounds (surfactants). Further surfactants customarily used in formulation technology will be known to the person skilled in the art or can be found in the relevant technical literature.
The agrochemical compositions usually comprise 0.01 to 99 % by weight, preferably 0.1 to 95 % by weight, of a compound of formula I, 99.99 to 1 % by weight, preferably 99.9 to 5 % by weight, of a solid or liquid adjuvant, and 0 to 25 % by weight, preferably 0.1 to 25 % by weight, of a surfactant.
Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ dilute formulations.
The compositions may also comprise further ingredients, such as stabilisers, antifoams, viscosity regulators, binders and tackifiers, as well as fertilisers or other active ingredients for obtaining special effects.
The Examples which follow illustrate the invention described above, without limiting the scope thereof in any way. Temperatures are given in degrees Celsius. Ph stands for phenyl.
Preparation Examples :
Example E1 : (S)-Λ/-r2-(3-Methoxy-4-prop-2-vnyloxy-phenyl)-ethvn-2-phenyl-2-prop-2- vnyloxy-acetamide
Figure imgf000023_0001
a) (S)-2-Hvdroxy-Λ/-r2-(3-methoxy-4-prop-2-vnyloxy-phenyl)-ethvn-2-phenyl-acetamide
2-(3-Methoxy-4-prop-2-ynyloxy-phenyl)-ethylamine hydrochloride (8.5 g, 35 mol) and N,N-di- isopropylethylamine (17 g, 0.13 mol) are dissolved in 100 ml of N,N-dimethylformamide. To this solution L-(+)-mandeIic acid [(S)-α-hydroxyphenylacetic acid] (5.0 g, 33 mmol) and (benzotriazol-1 -yloxy)-tris-(dimethylamino)-phosphonium hexafluorophosphate (16 g, 36 mmol) are added successively. The reaction mixture is stirred for 3 h at room temperature subsequently poured on ice-water and extracted several times with ethyl acetate. The combined organic layer is washed with brine, dried over sodium sulfate and evaporated in vacuo. The remaining oil is purified by chromatography on silicagel (ethyl acetate / hexane 1 : 1) to yield (S)-2-hydroxy-/V-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-phenyl- acetamide
1H-NMR (300 MHz, CDCI3): 2.72 (t, 1 H, C≡CH), 2.93 (q, 2H, CH2CH2), 3.72 (dt, 2H, CH2CH2), 4.01 (s, 3H, OCH3), 4.97 (d, 2H, OCH2), 5.20 (s, 1 H, CHOH), 6.28 (bs, 1 H, NH), 6.73 - 7.58 (m, 8H, CH arom.).
b) A 80 % solution of propargyl bromide in toluene (4.5 g, 30 mmol) is added slowly at room temperature to a mixture of (S)-2-hydroxy-/V-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)- ethyl]-2-phenyl-acetamide (8.0 g, 24 mmol), 30 % sodium hydroxide solution (12 ml, 118 mmol) and catalytic amounts of tetrabutylammonium bromide (75 mg) in 40 ml of dichloromethane. The reaction is stirred for 16 hours at +40°C. Subsequently the mixture is evaporated and the residue is diluted with water and dichloromethane. The phases are separated and the aqueous phase is extracted three times with dichloromethane. The combined organic layer is washed with brine, dried over sodium sulfate and evaporated. The remaining oil is purified by chromatography on silica gel (ethyl acetate / hexane 1 : 1 ) to give (S)-/V-[2-(3- methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-phenyl-2-prop-2-ynyloxy-acetamide. 1H-NMR (300 MHz, CDCI3): 2.41 (t, 1 H, C≡CH), 2.46 (t, 1 H, C≡CH), 2.73 (t, 2H, CH2CH2), 3.48 (m, 2H, CH2CH2), 3.79 (s, 3H, OCH3), 3.91 (dd, 1 H, OCH2), 4.12 (dd, 1 H, OCH2), 4.71 (d, 2H, OCH2), 4.93 (s, 1 H, CHO), 6.62 - 7.30 (m, 9H, CH arom., NH). M.p.: 81 - 83 °C.
According to the procedures of Example E1 the compounds listed in table E1 are obtained.
Table E1 : (Ph designates phenyl), the asymmetrical carbon is in (S)-form
Figure imgf000024_0001
Figure imgf000025_0001
Figure imgf000026_0001
Figure imgf000027_0001
Figure imgf000028_0001
Figure imgf000029_0002
obtained.
Table 1 : Compounds represented by the Formula 1.01
Figure imgf000029_0001
wherein the combination of the groups R1 ; R2, R3, R9 and R10 corresponds each to one row in table A. Table 2: Compounds represented by the Formula 1.02
Figure imgf000030_0001
wherein the combination of the groups R1 ( R2, R3, R9 and R10 corresponds each to one row in table A.
Table 3: Compounds represented by the Formula I.03
Figure imgf000030_0002
wherein the combination of the groups RΛ , R2, R3, Rg and R10 corresponds each to one row in table A.
Table 4: Compounds represented by the Formula 1.04
Figure imgf000030_0003
wherein the combination of the groups R^ R2, R3, R9 and R10 corresponds each to one row in table A.
Table 5: Compounds represented by the Formula I.05
Figure imgf000030_0004
wherein the combination of the groups R1 t R2, R3, Rg and R10 corresponds to each one row in table A. Table 6: Compounds represented by the Formula 1.06
Figure imgf000031_0001
wherein the combination of the groups R^ R2, R3, R9 and R10 corresponds each to one row in table A.
Table 7: Compounds represented by the Formula I.07
Figure imgf000031_0002
wherein the combination of the groups R^ R2, R3, Rg and R10 corresponds each to one row in table A.
Table 8: Compounds represented by the Formula I.08
Figure imgf000031_0003
wherein the combination of the groups R^ R2, R3, Rg and R10 corresponds each to one row in table A.
Table 9: Compounds represented by the Formula I.09
Figure imgf000031_0004
wherein the combination of the groups R1( R2, R3, Rg and R10 corresponds each to one row in table A Table 10: Compounds represented by the Formula 1.10
Figure imgf000032_0001
wherein the combination of the groups R1 ; R2, R3, Rg and Rio corresponds each to one row in table A.
Table 11 : Compounds represented by the Formula 1.11
Figure imgf000032_0002
wherein the combination of the groups R^ R2, R3, R9 and R10 corresponds each to one row in table A.
Table 12: Compounds represented by the Formula 1.12
Figure imgf000032_0003
wherein the combination of the groups R^ R2, R3, R9 and Rι0 corresponds each to one row in table A.
Table 13: Compounds represented by the Formula 1.13
Figure imgf000032_0004
wherein the combination of the groups R1 ; R2, R3, R and R1o corresponds each to one row in table A. Table 14: Compounds represented by the Formula 1.14
Figure imgf000033_0001
wherein the combination of the groups Ri, R2, R3, R9 and R10 corresponds each to one row in table A.
Table 15: Compounds represented by the Formula 1.15
Figure imgf000033_0002
wherein the combination of the groups Ri, R2, R3, R9 and Rio corresponds each to one row in table A.
Table 16: Compounds represented by the Formula 1.16
Figure imgf000033_0003
wherein the combination of the groups Ri, R2, R3, R9 and Rι0 corresponds each to one row in table A.
Table 17: Compounds represented by the Formula 1.17
Figure imgf000033_0004
wherein the combination of the groups Ri, R2, R3, R9 and R 0 corresponds each to one row in table A. Table 18: Compounds represented by the Formula 1.18
Figure imgf000034_0001
wherein the combination of the groups R1 f R2, R3, Rg and R10 corresponds each to one row in table A.
Table 19: Compounds represented by the Formula 1.19
Figure imgf000034_0002
wherein the combination of the groups Ri, R2, R3, R9 and Rι0 corresponds each to one row in table A.
Table 20: Compounds represented by the Formula I.20
Figure imgf000034_0003
wherein the combination of the groups Ri, R2, R3, R9 and Rι0 corresponds each to one row in table A.
Table 21 : Compounds represented by the Formula 1.21
Figure imgf000034_0004
wherein the combination of the groups Ri, R2, R3, Rg and Rι0 corresponds each to one row in table A. Table 22: Compounds represented by the Formula 1.22
Figure imgf000035_0001
wherein the combination of the groups Ri, R2, R3, Rg and Rι0 corresponds each to one row in table A.
Table 23: Compounds represented by the Formula I.23
Figure imgf000035_0002
wherein the combination of the groups R1 f R , R3, Rg and R10 corresponds each to one row in table A.
Table 24: Compounds represented by the Formula I.24
Figure imgf000035_0003
wherein the combination of the groups R1 f R2, R3, Rg and Rι0 corresponds each to one row in table A.
Table 25: Compounds represented by the Formula I.25
Figure imgf000035_0004
wherein the combination of the groups Ri, R2, R3, Rg and R10 corresponds each to one row in table A. Table 26: Compounds represented by the Formula 1.26
Figure imgf000036_0001
wherein the combination of the groups Ri, R2, R3, R9 and R10 corresponds each to one row in table A.
Table 27: Compounds represented by the Formula I.27
Figure imgf000036_0002
wherein the combination of the groups R1 ( R2, R3, R9 and Ri0 corresponds each to one row in table A.
Table 28: Compounds represented by the Formula I.28
Figure imgf000036_0003
wherein the combination of the groups Ri, R2, R3, R9 and R10 corresponds each to one row in table A.
Table 29: Compounds represented by the Formula I.29
Figure imgf000036_0004
wherein the combination of the groups Ri, R2, R3, R9 and R10 corresponds each to one row in table A. Table 30: Compounds represented by the Formula 1.30
Figure imgf000037_0001
wherein the combination of the groups Ri, R2, R3, Rg and Rio corresponds each to one row in table A.
Table 31 : Compounds represented by the Formula 1.31
Figure imgf000037_0002
wherein the combination of the groups R1 ( R2, R3, R9 and Rio corresponds each to one row in table A.
Table A: (Ph designates phenyl)
Figure imgf000037_0003
Figure imgf000038_0001
Figure imgf000039_0001
Figure imgf000040_0001
Figure imgf000041_0001
Figure imgf000042_0001
Figure imgf000043_0001
Figure imgf000044_0001
Figure imgf000045_0001
Formulations may be prepared analogously to those described in, for example, WO 95/30651. Biological Examples
D-1 : Action against Plasmopara viticola on vines a) Residual-protective action
Vine seedlings are sprayed at the 4- to 5-leaf stage with a spray mixture (0.02 % active ingredient) prepared from a wettable powder formulation of the test compound. After 24 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation for 6 days at 95-100 % relative humidity and +20°C. b) Residual-curative action
Vine seedlings are infected at the 4- to 5-leaf stage with a sporangia suspension of the fungus. After incubation for 24 hours in a humidity chamber at 95-100 % relative humidity and +20°C, the infected plants are dried and sprayed with a spray mixture (0.02 % active ingredient) prepared from a wettable powder formulation of the test compound. After the spray coating has dried, the treated plants are placed in the humidity chamber again. Fungus infestation is evaluated 6 days after infection.
Compounds of Tables 1 to 31 exhibit a good fungicidal action against Plasmopara viticola on vines. Compounds E1.002, E1.011 and E1.152 at 200 ppm inhibit fungal infestations in both tests D-1 a) and D-1b) by 80-100%. At the same time untreated plants showed pathogen attack of 80-100%.
D-2: Action against Phytophthora on tomato plants a) Residual-protective action
After a cultivation period of 3 weeks, tomato plants are sprayed with a spray mixture (0.02 % active ingredient) prepared from a wettable powder formulation of the test compound. After 48 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation of the infected plants for 5 days at 90-100 % relative humidity and +20°C. b) Systemic action
After a cultivation period of 3 weeks, tomato plants are watered with a spray mixture (0.02 % active ingredient based on the volume of the soil) prepared from a wettable powder formulation of the test compound. Care is taken that the spray mixture does not come into contact with the parts of the plants that are above the ground. After 96 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation of the infected plants for 4 days at 90-100 % relative humidity and +20°C. Compounds of Tables 1 to 31 exhibit a long-lasting effect against fungus infestation. Compounds E1.002, E1.011 , E1.151 and E1.152 at 200 ppm inhibit fungal infestations in both tests D-2a) and D-2b) by 80 - 100 %. At the same time untreated plants showed pathogen attack of 80 - 100 %.
D-3 : Action against Phytophthora on potato plants a) Residual-protective action
2-3 week old potato plants (Bintje variety) are sprayed with a spray mixture (0.02 % active ingredient) prepared from a wettable powder formulation of the test compound. After 48 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation of the infected plants for 4 days at 90-100 % relative humidity and +20°C. b) Systemic action
2-3 week old potato plants (Bintje variety) are watered with a spray mixture (0.02 % active ingredient based on the volume of the soil) prepared from a wettable powder formulation of the test compound. Care is taken that the spray mixture does not come into contact with the parts of the plants that are above the ground. After 48 hours, the treated plants are infected with a sporangia suspension of the fungus. Fungus infestation is evaluated after incubation of the infected plants for 4 days at 90-100 % relative humidity and +20°C. Fungal infestation is effectively controlled with compounds of Tables 1 to 31.
Compounds E1.002, E1.011 and E1.152 at 200 ppm inhibit fungal infestations in both tests D-3a) and D-3b) by 80 - 100 %. At the same time untreated plants showed pathogen attack of 80 - 100 %.

Claims

What is claimed is:
The compounds of formula I
Figure imgf000048_0001
including the optical isomers thereof and mixtures of such isomers, wherein
Ri is hydrogen, alkyl, cycloalkyl or optionally substituted aryl,
R2 and R3 are each independently hydrogen or alkyl,
R4 is alkyl, alkenyl or alkynyl,
R5, Re, R7, and R8 are each independently hydrogen or alkyl,
R9 is hydrogen, optionally substituted alkyl, optionally substituted alkenyl or optionally substituted alkynyl,
R10 is optionally substituted aryl or optionally substituted heteroaryl, and
Z is optionally substituted aryloxy, optionally substituted alkoxy, optionally substituted alkenyloxy or optionally substituted alkynyloxy
2. A compound according to claim 1 wherein the enantio-enriched form of the compound of formula I contains the pure enantiomer as displayed in an amount of at least 70%.
3. A compound according to claims 1 or 2 wherein the contents of the entio-enriched form contains the pure enantiomer as displayed in an amount of at least 80%, preferably above 90%, especially above 95%.
4. A compound according to any one of claims 1 to 3, wherein R is hydrogen, alkyl, cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by substituents selected from the group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may in turn be substituted by one or several halogens; alkoxy, alkenyloxy, alkynyloxy; alkoxy-alkyl; haloalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; halogen; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl; or alkynyloxycarbonyl; and R2 and R3 are independently of each other hydrogen or Cι-C4alkyl; and R4 is Cι-C8alkyl, C2-C8alkenyl, or C2-C8alkynyl; and
R5, R6, R7 and R8 are independently of each other hydrogen or Cι-C4alkyl; and R9 is hydrogen, C C4alkyl, Cι-C4haloalkyl, C3-C4alkenyl or C3-C4alkynyl; and R10 is aryl or heteroaryl, each optionally substituted with substituents selected from to group comprising alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, where all these groups may be substituted with one or more substituents selected from the group comprising halogen; alkoxy, alkenyloxy, alkynyloxy; alkoxy-alkyl; haloalkoxy; alkylthio; haloalkylthio; alkylsulfonyl; formyl; alkanoyl; hydroxy; cyano; nitro; amino; alkylamino; dialkylamino; carboxyl; alkoxycarbonyl; alkenyloxycarbonyl and alkynyloxycarbonyl; and Z is optionally substituted aryloxy wherein the aryl may be optionally substituted by one or more substituents selected from the group comprising halogen, CrC8alkoxy, C2-C8alkenyl- oxy, C2-C8alkynyloxy, Ci-Csalkoxy-d-Csalkyl, d-C8haloalkoxy, Cι-C8alkylthio, Cι-C8haIoal- kylthio, CrC8alkylsulfonyl, formyl, C2-C8alkanoyl, hydroxy, halogen, cyano, nitro, amino, Cι-C8alkylamino, di-Cι-C8alkylamino, carboxyl and C C8alkoxycarbonyl; or is optionally substituted C C8alkoxy, optionally substituted C2-C8alkenyloxy or optionally substituted C2-C8alkynyloxy, wherein each alkyl, alkenyl or alkynyl group may carry one or more substituents selected from the group comprising halogen, C C4alkyl, CrC4alkoxy, Cι-C4al- kylthio, C3-C6cycloalkyl, nitro, cyano, hydroxy, phenyl, mercapto, C C4alkylcarbonyl and Ci -C4al koxycarbonyl .
5. A compound according to any one of claims 1 to 4 wherein Ri is hydrogen, CrC8alkyl, C3-C8cycloalkyl, phenyl or naphthyl; phenyl and naphthyl being optionally substituted by one to three substituents selected from the group comprising C C8alkyl, C2-C8alkenyl, C2-C8al- kynyl, C C8haloalkyl, C C8alkoxy, CrC8haloalkoxy, C C8alkylthio, d-Cshaloalkylthio, Cι-C8alkylsulfonyl, halogen, cyano, nitro and Cι-C8alkoxycarbonyl; and R2 and R3 are hydrogen; and R4 is Cι-C6alkyl; and R5, R6 and R7 are hydrogen and R8 is hydrogen, methyl or ethyl; and R9 is hydrogen or Cι-C alkyl; and R 0 is phenyl, naphthyl or biphenyl, each optionally substituted by one to three substituents selected from the group comprising CrC8alkyl, C2-C8alkenyl, C2-C8alkynyl, Cι-C8haloalkyl, Cι-C8alkoxy, Cι-C8haloalkoxy, C C8alkylthio, CrCshaloalkylthio, CrC8alkylsulfonyl, halogen, cyano, nitro and C C8al- koxycarbonyl; and Z is CrC8alkoxy, C2-C8alkenyloxy, CrC8alkynyloxy, d-Csalk- oxy-CrC8alkoxy, C2-C8alkenyloxy-Cι-C8alkoxy, C2-C8alkynyloxy-Cι-C8alkoxy, CrCahaloalkoxy or C3-C8cycloalkyl-Cι-C8aIkoxy.
6. A compound of formula I according to any one of claims 1 to 5 wherein Ri is hydrogen, CrC8alkyl or phenyl optionally substituted by one to three substituents selected from the group comprising Cι-C8alkyl, d-C8haloalkyl, C C8alkoxy, C C8haIoalkoxy, d-C8al- kylthio, C C8haloalkylthio, halogen, cyano, nitro and C C8alkoxycarbonyl; and R2 and R3 are hydrogen; and R is C C alkyl, and R5, R6 and R7 are hydrogen and R8 is hydrogen or methyl; and R9 is hydrogen; and Rι0 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising Cι-C8alkyl, d-C8haloalkyl, C C8alkoxy, C C8haloalkoxy, Cι-C8alkylthio, CrCshaloalkylthio, halogen, cyano, nitro and CrC8alkoxycarbonyl; and Z is CrC8alkoxy, C2-C8alkenyloxy, C2-C8alkynyloxy or Cι-C alkoxy-C C2alkoxy.
7. A compound of formula I according to any on of claims 1 to 6 wherein Ri is hydrogen, d-C8alkyl or C3-C8cycloalkyl; and R2, R3, R5, Re, R7, Rs and R9 are hydrogen; and R4 is methyl or ethyl; and R10 is phenyl, naphthyl, 1 ,3-biphenyl or 1 ,4-biphenyl, each optionally substituted by one to three substituents selected from the group comprising C C8alkyl, C C8haloalkyl, C C8alkoxy, CrC8haloalkoxy, Cι-C8alkylthio, CrCshaloalkylthio, halogen, cyano, nitro and d-C8aIkoxycarbonyl.
8. A compound of formula I according to claim 1 selected from the group comprising (S)-2-(4-bromo-phenyl)-2-methoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-chloro-phenyl)-2-methoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(3,4-dichloro-phenyl)-2-methoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-bromo-phenyl)-2-ethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-chIoro-phenyl)-2-ethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(3,4-dichloro-phenyl)-2-ethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-bromo-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-propoxy- acetamide, (S)-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyI]-2-propoxy- acetamide,
(S)-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-propoxy- acetamide,
(S)-2-(4-bromo-phenyl)-2-cyclopropylmethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)- ethyl]-acetamide,
(S)-2-(4-chloro-phenyl)-2-cyclopropylmethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)- ethyl]-acetamide,
(S)-2-cyclopropylmethoxy-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy- phenyl)-ethyl]-acetamide,
(S)-2-(4-bromo-phenyl)-2-ethoxymethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-chloro-phenyl)-2-ethoxymethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(3,4-dichIoro-phenyl)-2-ethoxymethoxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)- ethyl]-acetamide,
(S)-2-allyloxy-2-(4-bromo-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-allyloxy-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-allyloxy-2-(3,4-dichloro-phenyI)-N-[2-(3-methoxy-4-prop-2-ynyIoxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-bromo-phenyl)-2-(but-2-enyloxy)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(but-2-enyloxy)-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(but-2-enyloxy)-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)- ethyl]-acetamide,
(S)-2-(4-bromo-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyI)-ethyl]-2-prop-2-ynyIoxy- acetamide,
(S)-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide,
(S)-2-biphenyl-4-yl-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-naphthalen-2-yl-2-prop-2-ynyloxy- acetamide,
(S)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy-2-p-tolyl-acetamide,
2-(4-ethyl-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy-2-(4-trifluoromethyl- phenyl)-acetamide,
(S)-2-(4-bromo-phenyl)-2-but-2-ynyloxy-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-but-2-ynyloxy-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-but-2-ynyloxy-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]- acetamide,
(S)-2-(4-bromo-phenyl)-N-[2-(3-methoxy-4-pent-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-2-(4-chloro-phenyl)-N-[2-(3-methoxy-4-pent-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-2-(3,4-dichloro-phenyl)-N-[2-(3-methoxy-4-pent-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide,
(S)-2-(4-fluoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2-ynyloxy- acetamide,
(S)-2-(3,4-difluoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide,
(S)-2-(4-chIoro-3-fluoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide, and
(S)-2-(3-chloro-4-fluoro-phenyl)-N-[2-(3-methoxy-4-prop-2-ynyloxy-phenyl)-ethyl]-2-prop-2- ynyloxy-acetamide.
9. A process for the preparation of a compound of formula I according to claim 1 , which comprises reacting a) the phenol of formula IV
Figure imgf000053_0001
wherein R4, R5, R6, R7, R8, Rg, R10 and Z are as defined for formula I with a compound of formula V
Figure imgf000053_0002
wherein Ri, R2 and R3 are as defined for formula I and wherein Y is a leaving group; or b) the acid of formula II
Figure imgf000053_0003
with an amine of formula VI
Figure imgf000053_0004
wherein Ri, R2, R3, R4, R5, R6, R7, Rs, Rg and Rι0 are as defined for formula I.
10. A composition for controlling and protecting against phytopathogenic microorganisms, comprising a compound of formula I according to claim 1 as active ingredient together with a suitable carrier.
1 1 . A composition according to claim 10 which comprises at least one additional f ungici- dally active compound, preferably selected from the group consisting of cymoxanil, trifloxystrobin, azoxystrobin, picoxystrobin, chlorothalonil, metalaxyl, metalaxyl-M, pyraclostrobin (BAS500F), dimethomorph, fosetyl-AI, copper-salts, acibenzolar-S-methyl, fludioxonil, mancozeb, folpet, fluazinam, iprovalicarb, zoxamid and (S)-2-(methylsulfonyl-amino)-3-methyl- butyric acid N-[2-{3-methoxy-4-(3-(4-chlorophenyl)-2-propyn-1 -yloxy)-phenyl}-ethyl]-amide.
12. The use of a compound of formula I according to claim 1 in protecting plants against infestation by phytopathogenic microorganisms.
13. A method of controlling and preventing an infestation of crop plants by phytopathogenic microorganisms, which comprises the application of a compound of formula I according to claim 1 as active ingredient to the plant, to parts of plants or to the locus thereof.
14. A method according to claim 13, wherein the phytopathogenic microorganisms are fungal organisms.
15. A process for the preparation of a compound of formula la according to claim 1
Figure imgf000054_0001
wherein Ri, R2, R3, R4, Rs, Re, R7, Rs, R9 and Ri0 are as defined for formula I in claim 1 and R12 is alkyl, alkenyl or alkynyl, which process comprises reacting a compound of formula XIII
Figure imgf000054_0002
with a compound of formula XIV
Y— R,„ ( XIV ) wherein R12 is alkyl, alkenyl or alkynyl and Y is a leaving group, e.g. bromine or chlorine or a tosyl, mesyl or trifluoromethylsulfonyl.
16. A process for the preparation of a compound of formula lb according to claim 1
Figure imgf000054_0003
which comprises reacting a compound of formula
Figure imgf000055_0001
wherein R4 and Rι0 are as defined for formula I in claim 1 , with a propargylating agent of formula XXII
Y CH^ — ≡CH ( XXII ) wherein Y is a leaving group, e.g. bromine or chlorine or a tosyl, mesyl or trifluoromethylsulfonyl.
PCT/EP2002/012848 2001-11-16 2002-11-15 Novel phenyl-propargylether derivatives WO2003041728A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US10/495,153 US20050026785A1 (en) 2001-11-16 2002-11-15 Novel phenyl-propargylether derivatives
AT02798312T ATE292108T1 (en) 2001-11-16 2002-11-15 NEW PHENYL-PROPARGYL ETHER DERIVATIVES
CA2464807A CA2464807C (en) 2001-11-16 2002-11-15 Phenyl-propargylether derivatives
BR0214139-6A BR0214139A (en) 2001-11-16 2002-11-15 Phenyl propargyl ether derivatives
CN028226925A CN101421230B (en) 2001-11-16 2002-11-15 Novel phenyl-propargylether derivatives
JP2003543615A JP4510455B2 (en) 2001-11-16 2002-11-15 Novel phenyl-propargyl ether derivatives
MXPA04004550A MXPA04004550A (en) 2001-11-16 2002-11-15 Novel phenyl-propargylether derivatives.
AU2002363600A AU2002363600A1 (en) 2001-11-16 2002-11-15 Novel phenyl-propargylether derivatives
EP02798312A EP1444197B1 (en) 2001-11-16 2002-11-15 Novel phenyl-propargylether derivatives
DE60203534T DE60203534T2 (en) 2001-11-16 2002-11-15 NEW PHENYL-PROPARGYL ETHER DERIVATIVES

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0127554.4 2001-11-16
GBGB0127554.4A GB0127554D0 (en) 2001-11-16 2001-11-16 Organic compounds

Publications (3)

Publication Number Publication Date
WO2003041728A1 true WO2003041728A1 (en) 2003-05-22
WO2003041728A8 WO2003041728A8 (en) 2004-03-25
WO2003041728A9 WO2003041728A9 (en) 2004-04-22

Family

ID=9925919

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/012848 WO2003041728A1 (en) 2001-11-16 2002-11-15 Novel phenyl-propargylether derivatives

Country Status (15)

Country Link
US (1) US20050026785A1 (en)
EP (1) EP1444197B1 (en)
JP (1) JP4510455B2 (en)
KR (1) KR100897729B1 (en)
CN (1) CN101421230B (en)
AR (1) AR037389A1 (en)
AT (1) ATE292108T1 (en)
AU (1) AU2002363600A1 (en)
BR (1) BR0214139A (en)
CA (1) CA2464807C (en)
DE (1) DE60203534T2 (en)
ES (1) ES2239272T3 (en)
GB (1) GB0127554D0 (en)
MX (1) MXPA04004550A (en)
WO (1) WO2003041728A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006136551A1 (en) * 2005-06-21 2006-12-28 Bayer Cropscience Sa Fungicide composition comprising a phosphorous acid derivative, a mandelamide type compound and a further fungicide compound
WO2007020381A3 (en) * 2005-08-15 2007-05-03 Syngenta Participations Ag Process for the synthesis of mandipropamid and derivatives thereof
WO2009138372A1 (en) * 2008-05-14 2009-11-19 Syngenta Limited Processes for the preparation of amides
WO2012070961A2 (en) 2010-11-26 2012-05-31 Sapec-Agro, Sa Fungicidal mixture

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW564244B (en) * 1999-01-11 2003-12-01 Novartis Ag Novel propargylether derivatives
JP5235378B2 (en) * 2007-10-24 2013-07-10 パナソニック株式会社 Semiconductor device
CN103181387B (en) * 2013-03-26 2015-06-17 河北省农林科学院植物保护研究所 Compound bactericide and application thereof
CN105475312B (en) * 2014-09-19 2018-01-02 江苏龙灯化学有限公司 A kind of composition pesticide
CN106508912B (en) * 2016-09-21 2019-10-29 江苏新农化工有限公司 Composition and its preparation and application containing mandipropamid and nitrile bacterium azoles

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017840A1 (en) * 1994-12-06 1996-06-13 Agrevo Uk Limited Heterocyclyl substituted hydroxyacetamide derivatives as fongicides
WO2000041998A1 (en) * 1999-01-11 2000-07-20 Syngenta Participations Ag Novel propargylether derivatives
WO2001087822A1 (en) * 2000-05-17 2001-11-22 Syngenta Participations Ag Novel phenyl-propargylether derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0532465B1 (en) * 1991-09-13 2002-07-10 Pentapharm A.G. Protein fraction for cosmetic and dermatological care of the skin
DE4319887A1 (en) * 1993-06-16 1994-12-22 Hoechst Schering Agrevo Gmbh Arylacetamides, processes for their preparation, compositions containing them and their use as fungicides
GT199800109A (en) * 1997-08-06 2000-01-13 DERIVATIVES OF N-SULFONILGLICINALQUINILOXIFENETILAMIDA MICROBICIDAS.
GB9900963D0 (en) * 1999-01-15 1999-03-10 Novartis Ag Organic compounds
FR2796839B1 (en) * 1999-07-26 2003-05-23 Serobiologiques Lab Sa USE OF A PROTEIN FRACTION OF THE VIGNA TRILOBATA PLANT SEED IN A COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION
GB0108339D0 (en) * 2001-04-03 2001-05-23 Syngenta Participations Ag Organics compounds
GB0223665D0 (en) * 2002-10-10 2002-11-20 Syngenta Participations Ag Organic compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017840A1 (en) * 1994-12-06 1996-06-13 Agrevo Uk Limited Heterocyclyl substituted hydroxyacetamide derivatives as fongicides
WO2000041998A1 (en) * 1999-01-11 2000-07-20 Syngenta Participations Ag Novel propargylether derivatives
WO2001087822A1 (en) * 2000-05-17 2001-11-22 Syngenta Participations Ag Novel phenyl-propargylether derivatives

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101198254B (en) * 2005-06-21 2011-10-05 拜尔农科股份公司 Fungicide composition comprising a phosphorous acid derivative, a mandelamide type compound and a further fungicide compound
WO2006136551A1 (en) * 2005-06-21 2006-12-28 Bayer Cropscience Sa Fungicide composition comprising a phosphorous acid derivative, a mandelamide type compound and a further fungicide compound
AU2006260959B2 (en) * 2005-06-21 2011-11-24 Bayer Intellectual Property Gmbh Fungicide composition comprising a phosphorous acid derivative, a mandelamide type compound and a further fungicide compound
US8129560B2 (en) 2005-08-15 2012-03-06 Syngenta Crop Protection, Inc. Process for the synthesis of mandipropamid and derivatives thereof
AU2006281293B2 (en) * 2005-08-15 2011-04-28 Syngenta Participations Ag Process for the synthesis of mandipropamid and derivatives thereof
WO2007020381A3 (en) * 2005-08-15 2007-05-03 Syngenta Participations Ag Process for the synthesis of mandipropamid and derivatives thereof
RU2470914C2 (en) * 2005-08-15 2012-12-27 Синджента Партисипейшнс Аг Method for synthesis of mandipropamid and derivatives thereof
TWI399363B (en) * 2005-08-15 2013-06-21 Syngenta Participations Ag Process
KR101305928B1 (en) * 2005-08-15 2013-09-12 신젠타 파티서페이션즈 아게 Process for the synthesis of mandipropamid and derivatives thereof
WO2009138372A1 (en) * 2008-05-14 2009-11-19 Syngenta Limited Processes for the preparation of amides
US8501993B2 (en) 2008-05-14 2013-08-06 Syngenta Limited Processes for the preparation of amides
AU2009248173B2 (en) * 2008-05-14 2013-10-10 Syngenta Limited Processes for the preparation of amides
WO2012070961A2 (en) 2010-11-26 2012-05-31 Sapec-Agro, Sa Fungicidal mixture

Also Published As

Publication number Publication date
ATE292108T1 (en) 2005-04-15
JP2005519030A (en) 2005-06-30
WO2003041728A9 (en) 2004-04-22
CN101421230B (en) 2011-04-13
BR0214139A (en) 2004-10-19
KR100897729B1 (en) 2009-05-15
CA2464807C (en) 2011-05-24
GB0127554D0 (en) 2002-01-09
AR037389A1 (en) 2004-11-03
ES2239272T3 (en) 2005-09-16
EP1444197B1 (en) 2005-03-30
MXPA04004550A (en) 2004-08-13
WO2003041728A8 (en) 2004-03-25
DE60203534D1 (en) 2005-05-04
KR20050044495A (en) 2005-05-12
US20050026785A1 (en) 2005-02-03
CN101421230A (en) 2009-04-29
JP4510455B2 (en) 2010-07-21
AU2002363600A1 (en) 2003-05-26
CA2464807A1 (en) 2003-05-22
DE60203534T2 (en) 2005-09-01
EP1444197A1 (en) 2004-08-11

Similar Documents

Publication Publication Date Title
EP1282595B1 (en) Novel phenyl-propargylether derivatives
AU2001260301A1 (en) Novel phenyl-propargylether derivatives
EP1444197B1 (en) Novel phenyl-propargylether derivatives
EP1373197A2 (en) Novel n-p-propargyloxyphenethyl-thioacetic acid amides
CA2461439C (en) Novel .alpha.-oxygenated or .alpha.-thiolated carboxylic acid phenethylamide derivatives
AU2002363599A1 (en) Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
US7700522B2 (en) α-Oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
KR20020091199A (en) Novel α-sulfin- and α-sulfonamino acid amide derivatives

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 1200400404

Country of ref document: VN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 21/2003 UNDER (51) REPLACE "A61K 35/78, 7/48, A61P 17/00" BY "C07C 235/34, C07C 323/52, C07D 307/79, 317/60, 319/18, 333/24, 333/28, 307/54, 261/08, 333/60, 277/64, 213/56, 239/26, 215/12, 241/42"

WWE Wipo information: entry into national phase

Ref document number: 2002798312

Country of ref document: EP

COP Corrected version of pamphlet

Free format text: PUBLISHED INTERNATIONAL SEARCH REPORT (6 PAGES) REPLACED BY CORRECT INTERNATIONAL SEARCH REPORT (3 PAGES)

WWE Wipo information: entry into national phase

Ref document number: 1098/DELNP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2464807

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 10495153

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/004550

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 20028226925

Country of ref document: CN

Ref document number: 1020047007452

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2003543615

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002798312

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2002798312

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 546083

Country of ref document: NZ